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Genome-wide Analysis of Streptococcus pyogenes  
Associated with Pharyngitis and Tissue Infections 
 
by Joe P. Ibrahim 
 
ABSTRACT 
 
Streptococcus pyogenes is a very important human pathogen, commonly isolated from 
the skin or throat of individuals. Belonging to the Group A Streptococcus (GAS), S. 
pyogenes is responsible for a myriad of infections both benign and life-threatening. 
Superficial infections by the microorganism are manifested through pharyngitis, 
tonsillitis, and localized skin infections, while the more invasive and often lethal 
infections include sepsis, streptococcal toxic shock syndrome (STSS), and necrotizing 
fasciitis. Various studies involving typing and molecular characterization of S. pyogenes 
have been performed to date; however next-generation sequencing (NGS) studies are still 
a handful. In this study, the genomes of nine S. pyogenes isolates associated with 
pharyngitis and skin infection were sequenced using the NGS approach, and subsequently 
analyzed for the presence of virulence genes, resistance elements, prophages, genomic 
recombination, and other genome wide features. All of the sequenced isolates were found 
to carry an array of genes encoding fibronectin binding proteins, exotoxin cytolysins, and 
immunoglobulin degrading enzymes. Additionally, all of the isolates encoded the 
characteristic streptococcal C5a peptidase, with a very high sequence homology observed 
between the individual isolates. The chromosomally encoded superantigens SpeG and 
SmeZ were naturally found in all the isolates, whereas differences were seen when 
studying phage-encoded ones. All of the genomes housed the SpeB while SpeK and SSA 
were found in two thirds and one third of the genomes respectively. Of the generated 
superantigen profiles, the two most common were SpeBGKZ and SpeBGJZ both of 
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which are mostly associated with sepsis and cellulitis. Interestingly, one isolate linked to 
emm1 serotype, had a superantigen profile associated with glomerulonephritis. 
Antimicrobial resistance determinants were identified to be mostly against three 
antimicrobial agents namely being: macrolide, fluoroquinolone and tetracycline. 
Macrolide resistance ABC efflux permeases were found in all of the sequenced genomes, 
fluoroquinolone resistance was seen in all of the isolates as well mainly through 
mutations in the DNA gyrase A and B subunits. Only two of the isolates however, 
showed elements of tetracycline resistance  suggesting a multi-resistant European clone 
lineage. Numerous phage and prophage elements were also detected on the streptococcal 
genomes, which is a characteristic feature of the species. The presence of such mobile 
elements explains the extensive genomic rearrangements seen in S. pyogenes. Large 
lineage diversity was also observed amongst the isolates which can also be attributed to 
genomic recombination events, mediated through phage integration instances or other 
horizontal gene transfer mechanisms. Phylogenetic tree construction revealed a strong 
link between our isolates and global clones causing invasive diseases. This study, that to 
our knowledge is the first of its kind in the region, elucidates the importance of the NGS 
approach as a tool to unlock different characteristics of bacterial genomes. Through this 
work, clinically relevant features of the S. pyogenes isolates, in addition to genome wide 
determinants were successfully detected, simultaneously. Studies similar to this one may 
be the cornerstone of both clinical and research oriented studies thus improving our 
knowledge and treatment approaches against such important human pathogens including 
S. pyogenes. 
 
Keywords: Streptococcus pyogenes, Genome analysis, Next-generation sequencing, 
NGS, Whole genome sequencing, WGS, Pharyngitis, Skin infections.  
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Chapter One 
INTRODUCTION 
Streptococcus pyogenes, belonging to the Group A Streptococcus (GAS) is an important 
human pathogen (Cunningham, 2000). Although it may not be as widespread as other 
pathogens, but the wide range of infections it causes can be as lethal (Walker et al., 
2014). Streptococcal infections are mostly seen in children aging four to seven years 
(Twisselmann, 2000). The majority of these infections is in the form of localized throat 
infections such as tonsillitis or pharyngitis, however these can develop into life 
threatening soft tissue infections. More lethal manifestations of the organism can lead up 
to invasive infections such as sepsis, acute rheumatic fever, acute glomerulonephritis, 
rheumatic heart disease, immune sequelae, and streptococcal toxic shock syndrome 
(STSS) (Cunningham, 2000; Walker et al., 2014). The reemergence of S. pyogenes in the 
last three decades, as being the etiological agent behind many diseases, especially in less 
developed countries, along with its growing antimicrobial resistance (Bisno, 1990), make 
it an “attractive” organism for research. The prevalence of the microbe is around 20% to 
30% in Europe with a higher percentage in less developed countries. Peek prevalence is 
mainly seen during the winter months and in temperate regions (Lamangni et al., 2008). 
Even after around 60 years of use, penicillin is still the drug of choice for treating S. 
pyogenes infections. However, clinical failures have been reported on many instances, 
these were attributed to environmental and intracellular resistance mechanisms 
(Pichichero & Casey, 2007). Complications in treatment are usually encountered when 
the patient is allergic to penicillin because resistance of the microorganism to other 
classes of antimicrobials is not uncommon. Resistance to macrolides in Europe ranges 
from 2.6% in Switzerland to 42% in Poland (Canton et al., 2002; Richter et al., 2005). 
The emergence of a resistance emm 12 clone in China has aggravated the situation where 
96% of GAS isolates were resistant to erythromycin (Yang et al., 2011). Resistance to 
tetracycline and fluoroquinolones has also been registered with 38% of the strains being 
resistant to the former globally (Ayer et al., 2007). A significant rise in fluoroquinolone 
resistance is also being reported in Europe with rates as high as 20% to 30% in some 
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countries (Van Heirstraeten et al., 2007; Montes et al., 2010). Successful treatment faces 
another major hurdle in cases where identification of the causative organism and 
diagnosis of the condition are delayed. S. pyogenes infections are mostly treatable when 
rapidly and accurately diagnosed, however non-supportive and supportive sequelae can 
arise from late identification, and develop into invasive complications (Centor et al., 
1981; Wong & Yuen, 2012). 
The true lethality of S. pyogenes lies in an arsenal of virulence factors present on the 
bacterial genome. These include pili, M proteins, leukocidins, streptolysins, complement 
inhibiting proteins, immunoglobulin-degrading enzymes, and superantigens 
(Cunningham, 2000; Walker et al., 2014). Coupled with efflux pumps and leukocyte 
evasion strategies, GAS isolates present a formidable opponent to the human immune 
system (Wong & Yuen, 2012). When studying the streptococcal genome, the successful 
detection and identification of all of these factors becomes of great importance. 
Traditionally, emm typing and pulsed-field gel electrophoresis (PFGE), in addition to 
Sanger sequencing methods, were routinely used to study GAS isolates and trace 
evolutionary and epidemiological relationships (Cunningham, 2000). With the advent of 
NGS techniques, research shifted to generating whole genome sequences of the organism 
in study (Beretelli & Greub, 2013). S. pyogenes genomes are known for their plasticity 
and genomic variation, namely due to horizontal gene transfer between bacterial cells, 
and the presence of prophages (Wong & Yuen, 2012). All of these features can confer 
virulence and resistance capabilities to GAS strains, in addition to influencing the 
regulation of existing genetic elements (Vjotek et al., 2008), a fact that further 
necessitates a broader look at the bacterial genome, rather than a localized one. 
Previously, studies in Lebanon, have laid down the foundations for a long-term 
evolutionary and epidemiological study of GAS strains isolated from Lebanon and 
bordering countries, mainly through emm and PFGE typing (Bahnan et al., 2011). The 
most prevalent emm types were found to be emm types 1, 22, and 28, all of which 
susceptible to penicillin and vancomycin but resistant to erythromycin and clindamycin 
(Bahnan et al., 2011). Another study outlined the relationship between the generated emm 
types and toxin genes, through antibiotic profiling and superantigen (Sag) detection 
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methods. The study delivered exhaustive evidence of the epidemiology of GAS isolates 
in Lebanon and the region. Additionally, an emergence of tetracycline resistance was 
registered, as compared to other previous reports from the country (Karaky et al., 2014).  
This study follows up the above works, in aim to build on the previous findings and 
expand to new aspects. In this work, the genomes of nine S. pyogenes strains associated 
with pharyngitis and skin infection isolated from a Lebanese hospital were sequenced 
through the whole-genome sequencing (WGS) approach and draft whole genomes were 
generated. Virulence, toxin, and resistance genes present on the bacterial genomes were 
identified and characterized. Multi-locus sequence types (MLST) were generated based 
on the genomic sequences as well as, emm types. Comparative analysis of the genomes 
with known global reference strains was performed, in addition to tracing phylogenetic 
relations between the studied isolates and their global counterparts. To our best 
knowledge, this is the first study of its kind in Lebanon and the Arab world. Additionally, 
WGS makes virtually all of the genetic content of the bacterial genome accessible to 
researchers and healthcare personnel alike. From there, analysis of the genetic content 
and detection of antimicrobial resistance and virulence genes make this technique an 
essential tool for rapid diagnosis and characterization of bacterial isolates 
Objectives: 
• Looking at genome-wide systems of regulation and environment response. 
• Screening the bacterial genome for the presence of virulence genes and pathogenicity 
islands. 
• Identifying genes responsible for the production of antibiotic resistance mechanisms. 
• Performing a comparative analysis between the different S. pyogenes isolates and 
their respective sequenced reference strains. 
• Tracing the evolutionary lineage among the different isolates through the construction 
of a single nucleotide polymorphism (SNP) based phylogenetic tree. 
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Chapter Two 
LITERATURE REVIEW 
2.1. Resurgence of severe Group A Streptococcal infections 
Normally, group A streptococci are extremely vulnerable to penicillin, however a 
reappearance of infections caused by such microorganisms has been documented as early 
as the mid-1980s (Kaplan, 1991). The first indicative of such a resurgence was due to an 
outbreak of rheumatic fever affecting around 200 children over a five year period. 
Subsequently, more reports of streptococcal infections surfaced in different areas of the 
United States. By the late 1980s, reports of even more severe infections, such as STSS, 
bacteremia, and invasive soft tissue infections, were documented in both the United 
States and Europe (Cunningham, 2000). The high morbidity and mortality rates attributed 
to such infections were linked to the appearance of new serotypes, namely the M antigen 
serotype 1 (Holm, 1996). The exact factors intrinsic to the global reemergence of group A 
streptococcal infections are yet to be answered (Efstratiou, 2000). Even though, modern 
medicine is now better suited to manage such infections, streptococcal infections are still 
on the rise in all parts of the world (Wong & Yuen, 2012). 
2.2. Bacteriology and identification 
S. pyogenes is a Gram-positive, catalase-negative, aerobic bacterium occurring as cocci 
arranged in chains. The species is largely interchangeable with the Group A 
Streptococcus (GAS) originally characterized by Lancefield (Brandt et al., 1999). S. 
pyogenes is usually distinguished from other Group A streptococci through the Voges-
Proskauer reaction (Facklam, 2002). Besides Lancefield’s antigen, S. pyogenes possesses 
a plethora of other surface antigens, essential for its classification, such as the M and T 
antigens. The M protein is encoded by the emm gene, resulting in a fibrillar protein found 
in the cell wall surface of the organism. When opsonizing antibodies in the host are 
absent, the M protein functions as an anti-phagocytic protein, inhibiting the deposition of 
complement components and binding several host immune proteins. Additionally, the M 
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protein is conductive in mucosal adhesion of the organism and has pro-inflammatory 
characteristics (Oehmcke et al., 2010). The T antigen on the other hand, is encoded by the 
tee gene and is mostly responsible for adherence to host cells through the formation of 
bacterial pili (Lizano et al., 2007). 
Traditionally, identification of S. pyogenes species was done through a positive throat 
culture, predominantly in patients with severe pharyngitis. The positive identification 
criterion of such a culture is the appearance of beta-hemolytic colonies on blood agar 
culture plates, amongst other normal flora species, which are usually non- or alpha-
hemolytic (Koneman et al., 1997). S. pyogenes may appear as highly mucoid to non-
mucoid, and the resulting colonies are catalyze negative. Optimally, GAS can be 
recovered by the use of blood agar plates containing sulfamethoxazole-trimethoprim to 
inhibit some of the normal flora and growth under anaerobic condition to enhance 
streptolysin O activity (Koneman et al., 1997). Another traditional method is the one 
based on the original work of Lancefield, in which streptococci are serologically grouped 
according to immunological differences in the composition of their cell wall. Verification 
of S. pyogenes is achieved through serological techniques such as the Lancefield capillary 
precipitin and the slide agglutination procedures (Koneman et al., 1997). Although highly 
accurate, such methods are plagued by their somewhat low speed (24h-48h). Due to the 
discussed shortfall, the use of a modified enzyme-linked immunosorbent assay (ELISA) 
was proposed by Facklam as an alternative rapid diagnostic test (Facklam, 1997).  
Moving from the traditional microbiological methods, molecular biology techniques, 
such as M and T protein typing, have proven to be essential in identifying S. pyogenes 
strains. In addition to serotyping the M protein, it was found that the protein contains 
variable moieties that are strain specific in addition to other highly conserved regions 
(Fischetti, 1989).  The M protein sequence is made up of four repeats, referred to as A 
through D. These regions differ in size as well as amino acid composition. The C and D 
regions, which are located on the C terminus are highly conserved between strains. The B 
region is considered to be a semi-variable region, while the A region is known as the 
hypervariable region, both of which located on the surface-exposed N terminus of the 
protein molecule (Fischetti, 1989). Since then, the M protein has been employed as an 
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epidemiological marker for GAS (Luca-Harari et al., 2009) and a new system of 
classification was proposed based on the sequence analysis of the emm gene (Wong & 
Yuen, 2012). Today, after nearly 60 year of being adopted, there exists 139 named emm 
types, with a corresponding 941 subtypes, in addition to 326 sequence types that remain 
unnamed (CDC, 2015). Instead of variable regions in the amino terminal, the T protein 
houses conserved motifs in that half of the molecule (Jones, et al., 1991). This fact has 
been exploited as a typing method through a laboratory agglutination test. Such a 
technique has also proved to be important for the identification of S. pyogenes strains 
especially when the M protein was not typeable (Beall et al., 1998). Nowadays, most S. 
pyogenes isolate T-types are associated with their corresponding M serotypes. The use of 
this dual typing system allows for improved identification of strain diversity especially in 
the current era of emerging streptococcal infections (Cunningham, 2000). 
2.3. Epidemiology and outbreaks 
S. pyogenes is a human-adapted pathogen, isolates primarily colonize, but are not limited, 
to epithelial surfaces such as the throat and the skin (Wagenvoort et al., 2005). GAS can 
also colonize other areas such as the gastrointestinal tract, the vagina, and the rectum, 
resulting in a wide range of superficial and invasive diseases (Liang et al., 2012). 
Transmission is usually direct via person-to-person through direct contact or airborne 
droplets. However, indirect transmission is possible specifically due to the fact that S. 
pyogenes can survive on inanimate surfaces such as blankets linens, and dust for up to 4 
weeks making good hygienic and disinfection practices a must (Wagenvoort et al., 2005). 
Interestingly, S. pyogenes infections are associated with foodborne transmission, often 
causing foodborne streptococcal pharyngitis and more sparingly scarlet fever (Wong & 
Yuen, 2012). The main routes for such infective cases are unpasteurized milk, eggs, and 
salads (Falkenhorst et al., 2008). Amongst all the pathogenic species of the GAS, S. 
pyogenes is the most frequently attributed to outbreaks occurring in families, schools, day 
care centers, prisons, and even in hospitals. Such epidemics are usually characterized by 
the multiplicity of their clinical manifestations (Lamagni et al., 2008). Asymptomatic 
carriage of the organism is a possibility occurring mainly in the pharynx of children. 
Studies have shown an occurrence of 3 to 26% in healthy children and a 23 to 58% 
7 
 
occurrence in children with sore throat. Such values are somewhat mimicked in healthy 
children and in ones with sore throat under the age of 5 years, with 3 to 17% and 17 to 
24% respectively (Shaikh et al., 2010) . The prevalence of S. pyogenes during community 
outbreaks was found to be as high as 88% in schools and day care centers (Deutscher et 
al., 2011). 
As mentioned previously, GAS strains are identified based on the 5’ variable region of 
their emm gene. Large-scale studies have successfully associated several emm types with 
geographical and socioeconomical areas of the world (Henningham et al., 2013; 
Smeesters et al., 2008; Steer et al., 2009). In industrialized societies for example, the most 
prevalent S. pyogenes isolates are of emm type 1, 3, 12, and 28, making up around 40% of 
GAS associated diseases in such areas (Shea et al., 2011; Wozniak et al., 2012), while 
these same emm types are isolated less frequently from the indigenous populations of less 
developed regions including Africa, the Pacific Islands, and the Indian subcontinent 
(Dhanda et al., 2011; Kumar et al., 2012). In addition to the socioeconomic factors, 
temporal and geographical variability, play an important role in the isolation of prevalent 
emm types in a certain region in a given year (Shea et al., 2011). Moreover, a significant 
variability is also recorded even within individual emm types; this phenomenon is mostly 
attributed to horizontal phage gene transfer (Beres et al., 2010). Collectively, the factors 
presented above, suggest that isolating specific emm types associated with epidemic 
behavior, is not a static action, but rather a dynamic one, constantly changing under 
changes in the host immune selective pressure (Walker et al., 2014). Dynamic as it may 
be, some emm types are still strongly associated with their respective diseases. Examples 
include emm types 1, 3, and 28 which are associated with invasive disease namely 
bacteremia, STSS, and necrotizing fasciitis. emm types 2, 4, 6, and 44/61 which are 
linked to superficial diseases, in addition to many others (Shea et al., 2011). 
2.4. Diseases 
S. pyogenes is one of the most important human pathogens. It can cause a myriad of 
diseases, ranging from pharyngitis, scarlet fever, impetigo, and pneumonia, to the more 
serious STSS, endocarditis, cellulitis, necrotizing fasciitis, and bacteremia (Rantala et al., 
2012). Recurrent GAS infections may also lead to deadly autoimmune diseases such as 
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acute rheumatic fever (ARF), rheumatic heart disease (RHD), and acute poststreptococcal 
glomerulonephritis (APSGN) (Lamagni et al., 2008). All in all, the above diseases are 
responsible for more than half a million deaths worldwide per year, making GAS, the 9th 
leading infectious agent of human mortality as ranked by the World Health Organization 
(WHO) (WHO, 2005). 
2.4.1. Superficial infections 
GAS cause more than 600 million cases of pharyngitis per year making it the most 
prevalent cause of bacterial pharyngitis (Carapetis et al., 2005). A sudden-onset of fever, 
coupled with the appearance of characteristic pus patches on the pharynx and tonsils, 
along with a sore throat caused by the inflammation of both structures, as well as an 
adenopathy in the cervical lymph nodes comprise the main clinical manifestations of 
pharyngitis. Other symptoms of the disease include general malaise, headache, nausea, 
and abdominal pain (Wessels, 2011). Limited to its uncomplicated form, pharyngitis is a 
self-limiting disease. It is usually transmitted through nasal discharge or droplets of 
saliva, and by that the incidence of transmittance is at its highest in crowded places 
(Bisno & Stevens, 2010). Figures in developed countries show a 15% incidence amongst 
school children with 4 to 10% in adults. These figures are 5 to 10 times higher in 
developing countries (Carapetis et al., 2005). 
Periodically, scarlet fever comes hand in hand with pharyngitis. Such a manifestation is 
attributed to GAS strains secreting streptococcal pyrogenic exotoxins, most prominently 
SpeA, encoded on a bacteriophage (Shulman & Tanz, 2010). A deep red erythematous 
rash is characteristic of scarlet fever, in addition to a “strawberry-colored” tongue, and 
exudative pharyngitis (Henningham et al., 2012). During the 19th century and early 20th, 
scarlet fever was an important cause of child mortality, but incidence plummeted over the 
last 200 years (Ralph & Carapetis, 2013), only to reemerge in recent history in Hong 
Kong and China (Wong & Yuen, 2012). 
Another superficial GAS infection is impetigo.  It is a contagious skin infection mostly 
spread via person-to-person contact and affecting mainly children in subtropical and 
tropical areas where living conditions are low and personal hygiene is poor (Valery et al., 
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2008). The infection is manifested by skin pustules that progressively enlarge, only to 
rupture and form thick scabs (Bisno & Stevens, 2010). Annually, impetigo is manifested 
in 111 million cases (Carapetis et al., 2005). 
2.4.2. Immune sequelae 
ARF is a systemic autoimmune disorder that is caused by repetitive episodes of untreated 
streptococcal pharyngeal infection. The symptoms of such a disease mainly include 
arthritis, endocarditis, and less frequently neurological manifestations namely Sydenham 
chorea (Lee et al., 2009). Less frequently seen, is erythema marginatum, and even more 
rarely, subcutaneous nodules (Cole et al., 2011). The danger of ARF lies in its potential to 
cause long-term heart damage termed rheumatic heart disease (RHD). ARF results in 
around 15.6 million deaths each year, with an estimated 282,000 new cases and 233,000 
deaths each year (Carapetis et al., 2005). RHD itself causes 2.4 million cases in children 
each year making the leading cause of infantile heart disease globally (Lee et al., 2009).  
Acute poststreptococcal glomerulonephritis is an autoimmune disorder affecting the 
kidneys. Clinically it is manifested through symptoms of edema, hypertension, urinary 
sedimentation, and decreased levels of complement components in the serum (Bisno & 
Stevens, 2010). The death toll of such a diseases in around 5,000 deaths annually with 
470,000 cases in total (Carapetis et al., 2005). 
2.4.3. Invasive diseases 
Occurring less frequently then their superficial, and autoimmune counterparts, invasive 
disease occur when the host epithelial barriers are breached by GAS and the underlying 
tissue colonized. These infections are characterized by a high rate of mortality and 
morbidity, with up to a quarter of the patients dying within 7 days of infection onset 
(Lamagni et al., 2008).  The most prevalent of such disease are cellulitis and bacteremia, 
followed by necrotizing fasciitis, pneumonia, endocarditis, peritonitis, osteomyelitis, 
meningitis, and septic arthritis. Furthermore, the listed cases can be complicated by the 
onset of the STSS, which increases the mortality rates within 7 days of infection onset, by 
almost four fold (Lamagni et al., 2008).  A global increase in the discussed cases has 
been noted since the late 1980s (Cole et al., 2011).  A decade ago, the WHO estimated 
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around 663,000 cases of GAS invasive diseases occurring yearly, resulting in around 
165,000 deaths worldwide (Carapetis et al., 2005). Generally, as with other GAS 
diseases, a higher incidence is observed in less developed countries and indigenous 
populations as opposed to developed countries (Walker et al., 2014). 
2.5. GAS cell adhesion 
Adhesion of the bacterial cells to host surfaces is mainly mediated by lipoteichoic acid 
(LTA) in addition to numerous bacterial cell surface proteins which adhere to both the 
host cell surfaces and the extracellular matrix (ECM) (Nobbs et al., 2009).  It is 
hypothesized that the initial attachment process is a two-step mechanism; the first 
involving a weak and/or long range binding, and the second involving a more targeted, 
high affinity interaction. It is thought that LTA initiates weak hydrophobic interactions 
between GAS cells and host cell surface elements and by that contributing to the initial 
attachment of the bacterium to host surfaces (Hasty et al., 1992). This initially established 
attachment is usually reinforced by long bacterial surface appendages such as pili, all of 
which paving the way for the second adherence stage. The second stage involves 
numerous high-affinity interactions namely protein-protein and lectin-carbohydrates 
bindings (Nobbs et al., 2009).  
GAS cell surface proteins include a wide range of adhesins that allow bacterial cells to 
interact with a multiple host cell elements, and thus giving GAS the ability to colonize a 
wide range of host tissue sites. The inherent proteins in question are attached to the 
bacterial cell surface through three types of linkages known to date. Some are covalently 
linked to the peptidoglycan of the cell wall through a C-terminal amino acid motif, others 
are covalently bound to the cell membrane via lipoprotein modifications to the N-
terminus (Scott & Barnett, 2006) and others are linked non-covalently to the cell surface 
components (Nobbs et al., 2009). 
2.5.1. GAS pili 
Pili are long, flexible, tube-like appendages extending up to 3 µm out of the surface of 
bacterial cells (Mora et al., 2005). Initially discovered in 2005, pili, also termed fimbriae, 
consist of heteromorphic structures amounting to a pilus shaft. The protein pilin is the 
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major component of the shaft, which is assimilated through the serial reactions of a 
transpeptidase, catalyzed by a class B sortase, SrtC (Kang et al., 2011). In addition to its 
catalytic activity, the class B sortase attaches minor pilin proteins, such as the adhesin 
Cpa and the basal pilin, to the pilus tip and to the cell membrane, respectively (Smith et 
al., 2010). The binding of the pilus to the bacterial cell wall is achieved through the 
action of sortase A (Nakata et al., 2011). Genes responsible for the biosynthesis of the 
pilus components, in addition to those encoding sortases are located in the fibronectin-
collagen-T-antigen (FCT) region of the bacterial genome and ordered as a pathogenicity 
island. Besides housing pilus genes, the FCT region also encodes fibronectin and 
collagen binding proteins as well as T-antigens (Bessen et al., 2002). Pili pathogenicity to 
the host comes from the fact that they directly act in bacterial adhesion. Pili act in the 
attachment of S. pyogenes strains, namely those belonging to the GAS M1 strain, to the 
epithelium of tonsils and primary keratinocytes in humans (Abbot et al., 2007). One 
peculiarity about pili is that they enhance bacterial cell aggregation in saliva through 
binding the salivary scavenger receptor glycoprotein gp340. The aggregation decreases 
bacterial adhesion to pharyngeal cells and by that, pili may be carrying out a bacterial 
clearance role by bringing bacteria in contact with immune components such as 
complement components, lactoferrin and sIgA (Edwards et al., 2008). Moreover, pili 
mediate the formation of biofilms, through promoting the formation of microcolonies on 
human cells (Manetti et al., 2007).  
2.5.2. M proteins 
M proteins are one of the most important virulence factors of GAS. The M protein is a 
surface protein that is linked to peptidoglycan layer of the bacterial cell wall through an 
LPxTG motif (Barnett et al., 2002). Structurally, the M protein is a dimer of two 
polypeptide chains, folded into an α-helical coiled-coil and projecting beyond the 
bacterial cell surface in a hair-like fashion (Philips et al., 1981). In addition to the fact 
that the M protein can be used as an epidemiological tool, the genetic variations housed 
in this protein have a wide range of physiological roles. Generally, M proteins function in 
the adherence and internalization of GAS cells into human keratinocytes and epithelial 
cells (Siemens et al., 2011). Some M proteins, namely M1, M3, and M6 have been found 
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to enhance bacterial colonization of human tissue through the direct binding to ECM 
components such as fibronectin (Cue et al., 2001). ECM proteins, through their ability to 
bind surface integrin α5β1, can also serve as bridging molecules linking bacterial cells to 
host cells expressing cell surface integrins. Moreover, integrin-mediated internalization 
of bacterial cells into host cells is generally promoted through such interactions (Wang et 
al., 2006). The M6 for example, can bind directly to host cell ligands, namely the 
keratinocyte membrane cofactor CD46 (Okada et al., 1995). In addition to the above 
functions, M1 can bind dermatan sulfate, heparin sulfate, and heparin, all of which are 
surface glycosaminoglycans (Frick et al., 2003). What’s more is that the M1 protein can 
foster interbacterial aggregation, and thus further enhancing bacterial adhesion to host 
epithelial cells and ultimately invasion (Frick et al., 2000).  
2.5.3. Other GAS ECM-binding proteins 
ECM proteins are a common target for pathogen host colonization, and GAS are no 
exception. To date, 11 fibronectin binding proteins have been characterized in GAS, and 
for the larger part, they are bound to the bacterial cell wall by a LPxTG motif. Such 
proteins can be divided into two categories; those that contain fibronectin binding repeats 
and those that do not. The first type includes S. pyogenes fibronectin-binding protein, 
serum opacity factor, and SfbX amongst others, while examples of the second type are M 
proteins, protein H, and glyceraldehyde-3-phosphate dehydrogenase (GAPDH)/Plr, and 
Shr amongst others (Yamaguchi et al., 2013). Another function of the latter type is the 
ability to bind both fibronectin, and laminin (Caswell et al., 2010). In addition to the 
above, a laminin binding protein, Lbp, is also found in some GAS strains, and functions 
in epithelial cell adherence (Terao et al., 2002). Plasminogen, which is another protein 
found on the cell surface, may also serve as a bridge between bacterial cells and their host 
counterparts. Such a protein interacts with the exposed integrins α1β1 and α5β1 on 
keratinocytes, thus inducing an integrin-mediated internalization process of GAS, 
analogous to the fibronectin-mediated reaction mentioned earlier. 
Although GAS have a wide array of adhesins, a somewhat high degree of functional 
redundancy can be postulated, yet the better part of adhesins are not found in all GAS 
strains. Only Fbo54, GAPDH, streptococcal surface enolase (SEN), and Lbp are found in 
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all GAS serotypes. It is important to note here that GAS adhesins are closely regulated 
based on environmental conditions (Kreikemeyer et al., 2003), and hence the production 
of functionally homologous adhesins by bacterial cells can be considered as an 
evolutionary adaptive mechanism that enables GAS to colonize the diverse host tissue 
types faced during an infection (Walker et al., 2014). 
2.6. Pathogenesis and resistance to host immune systems 
 
Figure 1: The arsenal of virulence factors expressed by GAS to foil the mounting of a 
successful immune response by the host (Walker et al., 2014). 
S. pyogenes is a pathogen adapted for infecting humans. GAS possess a large repertoire 
of surface-bound and secreted virulence factors that debilitate the hosts’ immune system 
and allow the organism to initiate and maintain an effective infection. GAS strains have 
the ability to resist opsonization, and phagocytosis, and inhibit complement deposition. 
They can also kill neutrophils and secrete antimicrobial peptides that impair immune 
functions (Walker et al., 2014). 
2.6.1. Resistance to opsonophagocytosis 
The first major hurdle facing bacteria towards a systemic spread is opsonization and 
phagocytosis by neutrophils, which are the main clearance mechanisms used by the host 
immune system. In order to overcome this hurdle, GAS hold a myriad of virulence 
14 
 
factors that confer resistance to opsonophagocytosis. These include complement 
inhibitors, such as M protein, hyaluronic acid capsule and streptococcal inhibitor of 
complement (SIC). In addition to leukocidal toxins, such as streptolysin O (SLO) and 
streptolysin S (SLS) that target and impair leukocytes. Adding to all that immunoglobulin 
(Ig) binding proteins and Ig-degrading enzymes such as endo-β-N-
acetylglucosamninidase of streptococci (EndoS) and streptococcal pyrogenic exotoxin B 
(SpeB) (Walker et al., 2014). 
2.6.1.1. Inhibitors of complement component deposition and activation 
The key component responsible for the inhibition of complement components is the M 
protein. It binds complement inhibiting proteins such as C4b binding protein (C4BP) 
(Berggard et al., 2001), factor H (Horstmann et al., 1988), and factor H-like protein 1 
(Johnsson et al., 1998), all of which undermine opsonophagocytosis by inhibiting 
complement deposition. Factor H targets the alternative complement pathway by 
enhancing the decay rate of the C3b opsonin and by that giving the bacterial cells more 
time to stay in the infected tissue (Horstmann et al., 1988). Other inhibitors, such as the 
M protein and Mrp-mediated fibrinogen binding proteins, impede the deposition of C3 
convertase on the bacterial surface and hence hindering phagocytosis (Courtney et al., 
2006; Sandin et al., 2006). M protein-mediated plasminogen binding acts in a like 
manner, by preventing the deposition of C3b opsonin on the bacterial cells, consequently 
hindering phagocytosis by neutrophils (Ly et al., 2014). Moreover, the M protein impairs 
the fusion of azurophilic granules inside the phagosome and inhibits by that its 
maturation (Staali et al., 2006). 
A hyaluronic acid capsule encases most of the GAS, and shields them from 
opsonophagocytosis (Dale et al., 1996). The capsule bestows many advantages upon 
GAS isolates; first and foremost it blocks antibodies from accessing bacterial surface 
epitopes, in addition to inhibiting complement components, and enhancing cell survival 
within neutrophils (Walker et al., 2014). The lack of encapsulation in GAS mutants is 
linked to vulnerability to phagocytic clearance and decreased virulence (Moses et al., 
1997). In patients with invasive GAS infection, where bacterial cells become 
disseminated in the blood, hyperencapsulated strains are isolated (Stollerman & Dale, 
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2008), suggesting an upregualtion of the capsule expression in the bloodstream (Gryllos 
et al., 2001). Mimicry is another important feature of the acid capsule as it is structurally 
very similar to the hyaluronic acid found on human cells enabling GAS to evade the host 
defenses (Cunningham, 2000). The capsule synthesis genes are encoded by a highly 
conserved hasABC synthase operon (Crater et al., 1995). 
SIC binds and negates the function of the C5b67 complex, preventing the formation of 
the subsequent membrane attack complex (MAC) (Fernie-King et al., 2001). SIC, 
uniquely seen in M1 and M57 GAS isolates (Akesson et al., 1996), is also responsible for 
binding immune factors such as secretory leukocyte protease inhibitor, cathelicidin 
antimicrobial peptide LL-37, α-defensin-1, and lysozyme. Additionally, SIC plays a role 
in bacterial adhesion to epithelial surfaces and mucosal colonization (Fernie-King et al., 
2002; 2004). SIC is encoded by the bacterial sic gene which is highly polymorphic, a fact 
that advocates a strong selective pressure to evade host neutralizing antibodies (Hoe et 
al., 2001). Other variants of SIC exits, and these bind the complements C6 and C7 (Binks 
et al., 2004).   
FbaA, which is a fibronectin binding protein, is present in many GAS serotypes. This 
protein binds factor H and FHL-1 of the complement component system, and by that 
hindering C3b from depositing on the bacterial cell surface. The outcome of such an 
event is the survival of GAS cells and their proliferation in human blood (Pandiripally et 
al., 2002).  
2.6.1.2. Leukocidins 
Leukocidins are extracellular toxins that directly attack the host immune cells, they are 
used by GAS to avoid defense mechanisms by the host. An example of leukocidins is 
SLO. It is a cytolysin that targets erythrocytes, neutrophils, macrophages, and epithelial 
cells by forming large pores in their cell membranes through oligemerization. This 
triggers fast caspase-dependent apoptosis and cell death (Timmer et al., 2009).  The SLO 
expression allows GAS cells to escape the phagocytic endosome after initial host cell 
invasion. Moreover, SLO reduces inflammatory cytokine responses such as the ones 
induced by tumor necrosis factor alpha (TNF-α) and interleukin-1β (IL-1β) (Hakansson 
et al., 2005). Accompanying SLO is the expression and co-transport of nicotinamide 
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dehydrogenase into the cytoplasm of host cells. Nicotinamide dehydrogenase drains 
stored intracellular energy and exacerbates cellular damage (Madden et al., 2001). In 
parallel, SLO promotes the invasion of the stratified squamous mucosa by streptococcal 
superantigens, further increasing host cell injury (Brosnahan et al., 2009). In some M1 
serotype GAS isolates, SLO has also been found to cause platelet-neutrophil aggregation, 
leading to tissue damage and vascular occlusion (Bryant et al., 2006).  
SLS is another potent membrane targeting hemolysin, it is structurally similar to the 
bacteriocin family of toxin, and found in all GAS strains. A nine-gene operon composed 
of the genes sagA through sagI encode SLS (Nizet et al., 2000). Similar to SLO, SLS also 
impairs host cells by inducing hydrophobic pores in their membranes. SLS is prolific in 
targeting leukocytes, erythrocytes, and platelets amongst others (Miyoshi-Akiyama et al., 
2005). The dissemination of GAS cells throughout host tissues is thought to be caused by 
the destruction of inflammatory cells by the hemolysin (Heath et al., 1999). Additionally, 
synergism exists between SLS, SpeB, and neutrophil-derived proteases, which further 
aggravates cellular damage (Ginsburg, 1999). The clinical manifestations, namely rapid 
tissue necrosis, caused by the secretion of SLS are typical of an invasive GAS infection 
(Sierig et al., 2003). 
2.6.1.3. Ig binding proteins 
Microbes that invade the human body are opsonized by antibodies to facilitate 
phagocytosis and complement activation. Of those antibodies, IgA, located primarily on 
mucosal surfaces, is the most efficient in preventing bacterial adhesion to host cells. 
Whereas IgG, found in the bloodstream, facilitates phagocytic contact with bacterial 
cells. In order to evade this mechanism, GAS express surface proteins that bind the Fc 
portions of IgA and IgG (Walker et al., 2014). These proteins are mainly the M proteins, 
M-related proteins (MRP), and M-like proteins (MLP). The former two bind IgA, while 
the latter bind IgG, undermining opsonization and complement activation (Carlsson et al., 
2003). There exist additional proteins under this same umbrella such as SibA, and the 
fibronectin binding repeats of the PrtF1/SfbI protein, the former binds the Fc and Fab 
regions of IgG, IgA, and IgM, whereas the latter binds the Fc region of IgG in a 
nonimmune fashion (Walker et al., 2014). 
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2.6.1.4. Ig-degrading enzymes 
Mac-1, Sib35, and MspA, are all IgG-degrading enzymes of S. pyogenes (IdeS). These 
impair neutrophil activation, phagocytosis, and reactive oxygen species release 
(Kawabata et al., 2002). IdeS is a cysteine protease that confers resistance to 
opsonophagocytosis by cleaving the lower Fc region of IgG. A related endopeptidase that 
binds the Fc portion of IgG and prevents phagocytes from recognizing GAS cells is the 
Mac-2 (Agniswamy et al., 2004).  
EndoS, a secreted endoglycosidase encoded by the ndoS gene, hydrolyzes residues on the 
heavy chain of IgG, impeding recognition by Fc receptors and ultimately inhibiting 
phagocytosis along with complement activation (Collin et al., 2002).  
A potent, broad-spectrum cysteine protease secreted by most GAS strains in the 
streptococcal pyrogenic exotoxin B (SpeB) (Hytonen et al., 2001). It is encoded by the 
ubiquitous speB gene in the late logarithmic phase of bacterial growth. It is notorious for 
its ability to hydrolyze IgG, IgA, IgM, IgD, as well as IgE (Collin et al., 2002). Its action 
initiates localized skin infections and proliferation of the organism in saliva (Shelburne et 
al., 2005).  
2.6.2. Resistance to antimicrobial peptides 
Antimicrobial peptides (AMPs) are small bactericidal molecules secreted by host cells. 
GAS resistance to such molecules is mainly through three mechanisms; degradation, 
electrostatic repulsion, or binding/inactivation (Walker et al., 2014). 
2.6.2.1. Degradation or inactivation 
In addition to cleaving Igs, SpeB has the ability to hydrolyze human cathelicidin LL-37 
(Nyberg et al., 2004). Cathelicidin is an AMP secreted by skin cells, mucosal cells, and 
neutrophils as part of the innate immune system (Epand et al., 1999). Surface bound 
plasmin on GAS cells also induces the degradation of cathelicidin (Hollands et al., 2012). 
SIC on the other hand, inhibits the peptide by simply binding and sequestering it (Fernie-
King et al., 2004).  
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2.6.2.2. Electrostatic repulsion 
D-alanine-D-alanyl carrier protein ligase (DltA) is a surface-bound amphiphilic 
polyglycerolphosphate GAS adhesion element (Sela et al., 2000). DltA improves GAS 
resistance to LL-37, acidic pH, lysozymes, and neutrophil-mediated killing (Kristian et 
al., 2005) by increasing the net positive charge of the surface of the bacterium. This is 
done by an alanine esterification reaction of lipoteichoic acid (LTA) governed by the 
dltABCD operon (Perego et al., 1995). 
2.6.3. Impairment of neutrophil killing mechanisms 
S. pyogenes cell envelope protease (SpyCEP or ScpC), is a cell wall associated peptidase 
that can disrupt neutrophil mustering to site of infection by cleaving the chemokine 
interleukin-8 (IL-8). This enhances GAS virulence and increases their resistance to 
neutrophil killing (Kurupati et al., 2010). 
The streptococcal C5a peptidase (SCPA), is a serine protease enzyme found on the 
bacterial cell surface encoded by the ubiquitous scpA gene within the mga regulon (Chen 
& Cleary, 1990). The peptidase cleaves the C5a binding site on polymorphonuclear 
leukocytes (PMNs), this leads to the inactivation of the chemoattractive activity of the 
anaphylatoxin and subsequently hinders phagocyte recruitment to the infected tissue. 
Furthermore, GAS phage-encoded DNases, such as Sda1 and Sda2, suppress toll-like 
receptors, inhibit alpha interferon (IFN-α) and TNF-α release, as well as degrading host 
secreted DNA-based microbicidal effectors (Walker et al., 2014). 
2.6.4. GAS superantigens 
Superantigens (SAgs) are non-glycosylated low-molecular-weight exoproteins, secreted 
by GAS. Their basic function is the overstimulation of the human immune processes 
(Spaulding et al., 2014). Superantigen secretion is detected mainly in patients with 
necrotizing fasciitis and STSS where the antigens cause a hyperinflamatory state 
mediated by overly elevated levels of interleukin-1β, IFN-γ, and TNF-α (Norrby-Teglund 
et al., 2000). To date, various GAS superantigens have been identified and classified. 
Streptococcal pyrogenic exotoxins include SpeA, SpeB, SpeC, and SpeG through SpeM, 
the streptococcal superantigen A (SSA), and the streptococcal mitogenic exotoxin Z 
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(SmeZ). Most superantigens are found on prophages in the bacterial genome, with only 
SpeG and SmeZ are encoded on the chromosome (Commons et al., 2014). Functionally, 
superantigens cross link T cell receptors (TCRs) on CD4+ T-cells with major 
histocompatibility complex class II (MHC II) molecules on B cells, monocytes, and 
dendritic cells, in a non-specific manner. This interaction leads to an exaggerated 
stimulation of the immune response followed by systemic toxicity, tissue necrosis, 
multiple organ failure, and septic shock (Norrby-Teglund & Johansson, 2013; Spaulding 
et al, 2014). Up to 20% of circulating T-cells can be activated by the superantigens, given 
the fact that each one of the toxins can bind a specific collection of V-beta gene products 
(Reglinski et al., 2014). Multiple allelic differences have been identified for numerous 
superantigens (Commons et al., 2014). This functional redundancy emphasizes the fact 
that GAS infection outcome is strongly influenced by host factors with respect to MHC II 
variation (Walker et al., 2014). 
2.7. Antibiotic resistance 
2.7.1. Penicillin sensitivity 
Penicillin remains the drug of choice for the treatment of most GAS infections. 
Susceptibility of the bacterium to the drug has not changed significantly in more than 50 
years, and GAS is still largely sensitive (Macris et al., 1998). Despite this vulnerability, 
some GAS infection do not respond to penicillin treatment causing recurrent infections 
and carriage, mainly in the throat (Kaplan et al., 2001). Studies have suggested that GAS 
escape penicillin by “hiding” inside epithelial cells which are not very permeable to the 
drug (Kaplan et al., 2006). Other suggestions include biofilm formation, and protection 
by other resident β-lactamase producing organisms (Brook et al., 2008). The deficiency 
in penicillin resistance in GAS isolates can be attributed to a high fitness cost associated 
with such a mutation. To date, β-lactamase activity has not been found in GAS, but 
monitoring is ongoing for emerging mutants (Pantosi et al., 2007).  
2.7.2. Macrolide resistance 
When patients are allergic to penicillin, macrolides such as erythromycin, azithromycin, 
and clarithromycin are administered as an alternative (Walker et al., 2014). Clindamycin, 
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a lincosamide, is used to treat lethal soft tissue infections as it decreases the production of 
streptococcal exotoxins (Carpetis, 2004). However resistance to both drug classes is 
found in GAS and fall under two mechanism: target site modification, or target drug 
efflux (Walker et al., 2014). Erythromycin ribosomal methylase genes, erm, are 
responsible for target site modification. Their resulting enzyme methylates an adenine 
residue in the 23S rRNA inducing a conformational change in the ribosome. This leads to 
a decrease in the binding of the antibiotics to their target site (Stevens et al., 1995). On 
the other hand, Macrolide efflux pump genes, mefA, confer resistance to the antimicrobial 
drug by encoding an efflux pump that exports 14- and 15- carbon-ring macrolides out of 
the bacterial cell (Seppala et al., 1998).  
2.7.3. Tetracycline resistance 
tetM and tetO are examples of ribosomal protection genes in GAS that confer resistance 
to tetracyclines (Chopra & Roberts, 2001). These possess an important GTPase activity 
that allows them to displace tetracyclines from the ribosome (Li et al., 2013). 
Additionally, efflux pumps encoded by the tetK and tetL genes, export the antibiotic out 
of the cell, however they are less common in GAS as compared to macrolide pumps. 
Normally, erm and mef genes responsible for macrolide resistance occur hand in hand 
with tetracycline resistance genes on mobile elements, making a high number of GAS 
isolates resistance to both drugs simultaneously (Malhotra-Kumar et al., 2005). 
2.7.4. Fluoroquinolone resistance 
Resistance to fluoroquinolones can be grouped into two types, low-level resistance and 
high level resistance, with the latter occurring less frequently than the former et al., 
2014). Low-level resistance is a result of mutations in a region of the bacterial 
topoisomerase IV. High-level resistance is caused by an additional mutation in the DNA 
gyrase genes (Montes et al., 2010). Both mutations can be acquired spontaneously or 
through horizontal gene transfer. Recently, fluoroquinolone resistance is increasing, 
largely due to the clonal expansion of resistant GAS strains (Pletz et al., 2006).  
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2.8. Whole genome sequencing approach 
Since the completion of the human genome project in 2003, major changes have been 
incurred in the genome sequencing approach, that have taken the process far from the 
days of the traditional Sanger sequencing technique (Venter et al., 2001). Advances in 
molecular techniques in addition to improvement of the sequencing algorithms meant that 
WGS became a routine, yet powerful tool for both diagnostic and research purposes 
(Mardis, 2008). In the new high throughput technique, genomic DNA is first sheared into 
fragments of distinct sizes, and then amplified and ligated with specific end-adapters. 
Oversampling of the ends of these fragments then generates millions of paired-end 
sequencing reads which when overlaid and assembled using the necessary algorithms, 
generate an almost complete genome (Beretelli & Greub, 2013). WGS effectively kick 
started in 2004, when the sequencing instruments became commercially available 
(Mardis, 2008). Since then, countless draft and complete genomes have been sequenced 
from both prokaryotic and eukaryotic organisms (Hasman et al., 2013).  
 
Figure 2: Timeline of next generation sequencing showing important milestones in the 
journey from Sanger sequencing to high throughput sequencing. (Bertelli & Greub, 2013) 
The first GAS genome was fully sequenced in 2001, by Feretti and colleagues from a 
strain isolated form a wound infection (Feretti et al., 2001). Since then, at least 18 
complete genomes of S. pyogenes have been published including M types 1 through 6 
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and 12, 18, 28, and 49 (NCBI,  2015). The size of the S. pyogenes genome ranges from 
1.82 Mbp to 1.95 Mbp averaging at 1.88 Mbp with a G+C content of about 38.5 mol%. A 
high degree of plasticity was noted amongst the genomes in addition to a large genetic 
variability. Both of these features are mainly attributed to the presence of prophages or 
prophage-like elements on the bacterial genomes (Wong et al., 2012). WGS of S. 
pyogenes isolates allows scientists to take a closer look at the genomic composition of 
disease causing strains. This improves our understanding of bacterial evolution, 
outbreaks, and transmission, in addition to monitoring emerging antibiotic resistance. 
WGS has, in many instances, replaced traditional molecular techniques used for studying 
GAS, namely M-typing MLST and PFGE, due to the augmented accuracy and sensitivity 
of the technique (Ben Zakour et al., 2012).  Additionally, comparative genomic analysis 
and reference mapping of generated genomes, allows for a fine-scale epidemiological 
discrimination of closely related bacterial isolates (Lewis et al., 2010).  
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Chapter Three 
MATERIALS AND METHODS 
3.1. Ethical Approval 
Ethical approval was not required as clinical isolates were collected and stored as part of 
routine clinical care. Clinical isolates and patient records/information were anonymized 
and de-identified prior to analysis. 
3.2. Bacterial isolates 
This study was conducted on nine S. pyogenes bacterial isolates collected from the 
American University of Beirut Medical Center (AUBMC). The samples were isolated 
from throat and pus swabs of patients with streptococcal infections, and were cultured 
overnight on Trypticase Soy Agar (TSA) (Bio-Rad, USA) medium for subsequent 
experimental work. 
3.3. DNA extraction 
Bacterial DNA was extracted using the Nucleospin Tissue kit (Macherey-Nagel, 
Germany) and following the manufacturer’s instructions.  
3.4. Genome sequencing: 
After fluorescent DNA quantification using Qubit 3.0 fluorometer (Life technologies, 
Carlsbad, CA), the samples were prepared for multiplexed, paired-end sequencing on a 
MiSeq Desktop Sequencer (Illumina, Inc., San Diego, CA). For each isolate, 1 ng of 
input DNA was used for fragmentation, indexing, and amplification by the Nextera XT 
library prep kit (Illumina, Inc., San Diego, CA) and following the manufacturer’s 
instructions. The subsequent clean up steps were performed using the AMPure XP PCR 
purification beads (Agencourt, Brea, CA) and again following instructions supplied by 
the Illumina manual. The resulting individual DNA libraries with fragments ranging from 
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500-1000 bp were quantified by quantitative PCR on a CFX96 (Bio-Rad, USA) in 
triplicate at two concentrations, 1:1,000 and 1:2,000, using the Kapa library 
quantification kit (Kapa Biosystems, Woburn, MA). Based on the individual library 
concentrations, equimolar pools of no more than 12 indexed libraries were prepared at a 
concentration of at least 1 nM using 10 mM Tris-HCl (pH 8.0) and 0.05% Tween 20. To 
ensure accurate loading onto the flow cell, the same quantification method was used to 
quantify the final pools. Finally the pooled paired-end libraries were sequenced on a 
MiSeq Desktop Sequencer to a read length of at least 250 bp.  
3.5. Analysis of sequencing results 
3.5.1. Genome assembly   
The sequenced genomes were assembled de novo using A5 while keeping default 
parameters. This pipeline automates the processes of data cleaning, error correction, 
contig assembly, scaffolding, and quality control (Tritt et al. 2012).  
Reference mapping to the closest reference strains (S. pyogenes MGAS6180 CP000056, 
S. pyogenes MGAS10394 CP000003, S. pyogenes M1476 AP012491,  S. pyogenes 
M1GAS SF370 NC002737 S. pyogenes NZ131 CP000829, S. pyogenes A20 CP003901, 
S. pyogenes 7F7 PRJNA238516) was performed using the MIRA assembler v4.0.2. 
(Chevreux et al., 1999). Reference strains were downloaded from the NCBI ftp website 
(ftp://ftp.ncbi.nih.gov/genomes/Bacteria/). 
3.5.2. Genome annotation using RAST 
The RAST server (http://rast.nmpdr.org) was used to annotate the obtained de novo 
assemblies. RAST was used for the identification of protein encoding, rRNA, and tRNA 
genes, as well as for assigning gene functions and predicting subsystems present on the 
genomes (Aziz et al., 2008; Overbeek et al., 2014). 
3.5.3. Determination of resistance genes, virulence genes, and pathogenicity 
Resistance and virulence genes, amongst other pathogenic determinants found on the 
streptococcal genomes, were identified by mapping the WGS data to online databases. 
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The SEED viewer service from RAST proved to be very useful in extracting all the 
genetic elements found on the sequenced bacterial genomes. It was used, combined with 
the web tools provided by the Center for Genomic Epidemiology (CGE) website 
(www.genomicepidemiology.org) to get a detailed list of the genetic elements in 
question. The ResFinder 2.1 web server was used to identify acquired antimicrobial 
resistance genes present on the bacterial genome, the job was run with the website’s 
default parameters (Zankari et al., 2012). ResFinder detects the presence of resistance 
genes, but does not confirm their functional integrity and expression. Resistance to 
acquired mutations in housekeeping genes, is another feature, the service misses. Hinging 
on the ResFinder hits, a resistance profile was established using phenotypes from 
previous published studies.  Virulence genes were determined using the VirulenceFinder 
1.2 service from the same website (Joensen et al., 2014). The PathogenFinder 1.1 service 
from CGE, was used to obtain an overview of the pathogenic gene families in the 
genomes (Cosentino et al., 2013).  
3.5.4. Multi-locus sequence typing (MLST) and plasmid detection 
MLST typing of the isolates was done by mapping the WGS data to an online database, 
using CGE’s MLST 1.7 server (Larsen et al., 2012). Plasmid detection was also achieved 
using the website’s PlasmidFinder 1.2 web service with a 95% selection threshold 
however no plasmids were detected for any of the isolates (Carattoli et al., 2014). 
3.5.5. Phage and mobile element detection 
Phage detection was done using the publically available Phage Search Tool (PHAST) 
(http://phast.wishartlab.com/index.html) (Zhou et al., 2011). This tool provides the 
closest identity match for detected phages in addition to their site of integration. Phage 
sequences were then annotated using RAST in order to determine the genes carried by the 
latter. 
3.5.6. CRISPR detection 
CRISPR gene detection was done using the previously described gene annotation server 
(RAST). Furthermore, CRISPR loci were individually reverified using the publically 
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available CRISPRfinder program (http://crispr.u-psud.fr/Server/) (Grissa et al., 2007) and 
the genes in question manually BLASTed against the NCBI nucleotide database.  
3.5.7. SNPs detection and phylogenetic tree construction 
SNPs calling, filtering and alignment were done using CSI Phylogeny 1.0a web service 
(https://cge.cbs.dtu.dk/services/CSIPhylogeny) (Kaas et al., 2014). Maximum parsimony 
tree visualization was done using the freely available FigTree v1.4.2 
(http://tree.bio.ed.ac.uk/software/figtree/). 
3.5.8. Circular genomes 
Circular genome visualization was done using two different tools. Comparative figure 
were generated using the CGView server at the publically available Stothard Research 
Group website (http://stothard.afns.ualberta.ca/cgview_server/) (Grant & Stothard, 2008). 
Informative figures for each sample were also generated using DNAPlotter release 1.11 
(Carver et al., 2009). 
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Chapter Four 
RESULTS 
4.1. Genome assembly and general genome features 
An average of 2,503,465 paired-end reads per sample were generated. Quality trimming 
and error correction of the reads resulted in an average of 1,976,732 high-quality reads. 
The initial assembly resulted in the following: for JI1, 174 contigs contained in 141 
scaffolds; JI2, 31 contigs contained in 27 scaffolds; JI3, 29 contigs contained in 24 
scaffolds; JI4, 51 contigs contained in 35 scaffolds; JI5, 37 contigs contained in 23 
scaffolds; JI6, 20 contigs contained in 18 scaffolds; JI7, 155 contigs contained in 149 
scaffolds; JI8, 181 contigs contained in 175 scaffolds; and JI10, 15 contigs contained in 
11 scaffolds. During scaffolding, some contigs were merged based on short overlaps and 
read-pair information, yielding a reduced final collection of contigs. The final draft 
genome sequences consisted of 169 contigs for JI1, including a combined 1,926,136 
bases; 27 contigs for JI2, including a combined 1,727,785 bases; 27 contigs for JI3, 
including a combined 1,747,856 bases; 46 contigs for JI4, including a combined 
1,911,191 bases; 30 contigs for JI5, including a combined 1,813,658 bases; 21 contigs for 
JI6, including a combined 1,733,542 bases; 168 contigs for JI7, including a combined 
1,952,183 bases; 180 contigs for JI8, including a combined 1,916,939 bases; and 15 
contigs for SP10, including a combined 1,771,191 bases. The G+C contents of the chosen 
isolates ranged between 38.2% and 38.5% with an average of 38%. On average, the 
sequenced genomes housed an average of 1844 open reading frames (ORFs) with 1752 of 
them encoding proteins. Additionally 57 tRNAs and 6 rRNAs were identified on average. 
The average gene size was 868 bp with coding sequences covering 85% of the genomes 
(Table 1). An average of 1250 discrete subsystems were identified on the sequenced 
genomes. Genes responsible for nutrient metabolism constituted the biggest part of the 
subsystems present on the genome, followed by genes encoding virulence factors and 
bacterial cell wall and capsule synthesis (Figure 1).  MLST types were also successfully 
identified and the isolates were found to be of various sequence types (ST): types; ST-36, 
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ST-304, ST-101, ST-52, ST-28, ST-46, ST-109, and ST-167. ST types were then 
correlated to emm types generated in an earlier study as well as to the disease associated 
with these typing patterns (Table 2) and were found to be mostly compatible with the site 
of isolation from the infection. 
Table 1: General features of the sequenced S. pyogenes genomes. 
Feature JI1 JI2 JI3 JI4 JI5 JI6 JI7 JI8 JI10 
Genome Size (bp)  1,926,1
36 
1,727,7
85 
1,747,8
56 
1,911,1
91 
1,813,6
58 
1,733,5
42 
1,952,1
83 
1,916,9
39 
1,771,1
91 
No of Contigs 171 34 32 48 40 23 160 186 17 
G+C content (mol 
%) 
38.4 38.4 38.4 38.2 38.4 38.4 38.4 38.5 38.4 
No. of genes 1991 1694 1725 1905 1832 1698 2041 1971 1740 
No. of potein-
encoding genes 
1905 1595 1635 1820 1747 1609 1948 1867 1645 
No. of coding 
sequences 
1907 1669 1711 1923 1824 1692 1937 1866 1740 
No. of subsystems 317 313 311 317 319 314 316 322 317 
No. of tRNAs 56 65 56 54 57 54 56 56 56 
No. of rRNAs 7 7 6 6 9 4 5 10 4 
Avg. gene size (bp) 847 894 882 855 861 890 844 853 883 
Avg. gene cover (%) 83.7 86.6 86.5 86.2 86.7 86.8 83.5 82.8 86.6 
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Figure 3: Average subsystem category distribution in the streptococcal genome. The pie 
chart shows the subsystem related genes as a percentage of the whole genomic content. 
Numbers next to the label entries indicate the number of genes involved in a particular 
subsystem. 
Table 2: The relationship between emm types (McGregor et al., 2004), MLST types, and 
diseases (Enright et al., 2001) in addition to site of isolation. emm pattern A-C is usually 
linked to upper respiratory tract infections (URT), pattern D is linked to skin infections 
while pattern E represents a generalist group. The seven housekeeping genes under study 
were gki, gtr, muri, mutS, recP, xpt, yqiL.  
Isolate emm Type emm 
Pattern 
ST-Type Tissue preference/ 
Associated Disease 
Site of 
Isolation 
JI1 12 A-C ST-36 Throat/URT Swab, throat 
JI2 108 D ST-304 Skin/- Swab, pus 
JI3 89 E ST-101 No preference/URT Swab, throat 
JI4 28 E ST-52 No preference/ Invasive Swab, throat 
JI5 1 A-C ST-28 Throat/Invasive Swab, pus 
JI6 89 E ST-101 No preference/URT Swab, throat 
JI7 22 E ST-46 No preference/Invasive Swab, throat 
JI8 85 D ST-109 Skin/Skin  Swab, throat 
JI10 118 E ST-167 No preference/- Swab, throat 
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4.2. Representative and comparative circular genomes 
The genomes of only two isolates, JI1 and JI6, are chosen as representative strains to be 
graphically displayed. The rest of the individual genomes can be found in ANNEX I.  
 
Figure 4: Circular representation of the S. pyogenes JI1 genome. The tracks represent 
(Outside inwards) coding sequences on the forward strand, coding sequences on the 
reverse strand, rRNAs, tRNAs, putative phages and phage elements, GC plot and GC 
skew with black indicating above average values and grey indicating below average ones.  
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Figure 5: Circular representation of the S. pyogenes JI6 genome. The tracks represent 
(Outside inwards) coding sequences on the forward strand, coding sequences on the 
reverse strand, rRNAs, tRNAs, putative phages and phage elements, GC plot and GC 
skew with black indicating above average values and grey indicating below average ones.  
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Figure 6: Comparative circular representation of the S. pyogenes JI1 isolate genome 
BLASTed against the genomes of three reference strains. Circular tracks show (from 
outside inwards) clockwise coding regions, anticlockwise coding regions, S. pyogenes 
MGAS6180 BLAST comparison, S. pyogenes NZ131 BLAST comparison, S. pyogenes 
M1GAS BLAST comparison, GC content, GC skew.  In the BLASTN alignment tracks, 
white regions indicate parts of the input sequence that did not yield a BLAST hit, while 
the color gets gradually darker as the number of hits increases. Regions with a 
pronounced color indicate numerous BLAST hits, such regions are commonly attributed 
to rRNAs or tRNAs or repetitive sequences for which several similar sequences in the 
comparison genome were found. 
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Figure 7: Comparative circular representation of the S. pyogenes JI6 isolate genome 
BLASTed against the genomes of three reference strains. Circular tracks show (from 
outside inwards) clockwise coding regions, anticlockwise coding regions, S. pyogenes 
MGAS6180 BLAST comparison, S. pyogenes NZ131 BLAST comparison, S. pyogenes 
M1GAS BLAST comparison, GC content, GC skew.  In the BLASTN alignment tracks, 
white regions indicate parts of the input sequence that did not yield a BLAST hit, while 
the color gets gradually darker as the number of hits increases. Regions with a 
pronounced color indicate numerous BLAST hits, such regions are commonly attributed 
to rRNAs or tRNAs or repetitive sequences for which several similar sequences in the 
comparison genome were found. 
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4.3. Virulence factors 
A plethora of genes encoding virulence factors was detected on the sequenced genomes 
(Table 3). Some of these elements were conserved between all of the isolates and had 
similar gene sizes such as the C5a peptidase gene, whereas others showed high variation 
in sequence, homologue count, and size, namely the M protein family. BLASTing of 
individual gene sequences against the NCBI database gave the needed information about 
the gene product identity and origin. 
Table 3: Genes encoding the most important virulence factors on the S. pyogenes 
genomes with their respective sizes. *phage-encoded elements. Fbp: fibronectin-binding 
protein, IgAR: immunoglobulin A receptor. 
 
Factor
name size (bp) name size (bp) name size (bp) name size (bp) name size (bp)
emm 5 1728 IgAR 1083 em 1107 emm 858 emm 1329
emm 1329 IgAR 1104 emm 1182
Fbp 1167 Fbp 1278 Fbp 1155
name size (bp) name size (bp) name size (bp) name size (bp) name size (bp)
ska 1323 ska 1323 ska 1323 ska 1323 ska 1323
name size (bp) name size (bp) name size (bp) name size (bp) name size (bp)
cfa 774 cfa 774 cfa 774 cfa 774 cfa 774
name size (bp) name size (bp) name size (bp) name size (bp) name size (bp)
hyl 2418 hyl 2418 hyl 2418 hyl 2418 hyl 2418
name size (bp) name size (bp) name size (bp) name size (bp) name size (bp)
scpA 3504 scpA 3546 scpA 3549 scpA 3549 scpA 3495
name size (bp) name size (bp) name size (bp) name size (bp) name size (bp)
endoS ~2988 endoS ~2988 endoS ~2988 endoS ~2988 endoS ~2988
name size (bp) name size (bp) name size (bp) name size (bp) name size (bp)
sic N/A sic N/A sic N/A sic N/A sic 927
name size (bp) name size (bp) name size (bp) name size (bp) name size (bp)
spd1 816 spd1 816 spd1 816 spd1 816 spd1 816
name size (bp) name size (bp) name size (bp) name size (bp) name size (bp)
sdA 981 sdA N/A sdA 981 sdA 981 sdA 981
Factor
name size (bp) name size (bp) name size (bp) name size (bp)
ennX* 1107 emm 117 IgaR 1146 Fbp 1275
IgAR 1083 emm 921 IgAR 1209 igA 1104
emm 1278 IgAR 1098 Fbp 1248 enn 1065
Fbp 1167
name size (bp) name size (bp) name size (bp) name size (bp)
ska 1323 ska 1323 ska 1323 ska 1323
name size (bp) name size (bp) name size (bp) name size (bp)
cfa 774 cfa 774 cfa 774 cfa 774
name size (bp) name size (bp) name size (bp) name size (bp)
hyl 2418 hyl 2529 hyl 2418 hyl 216
hyl 2202
name size (bp) name size (bp) name size (bp) name size (bp)
scpA 3549 scpA 3549 scpA 567 scpA 3549
scpA 3600
name size (bp) name size (bp) name size (bp) name size (bp)
endoS ~2988 endoS ~2988 endoS ~2988 endoS ~2988
name size (bp) name size (bp) name size (bp) name size (bp)
sic N/A sic N/A sic N/A sic N/A
name size (bp) name size (bp) name size (bp) name size (bp)
spd1 816 spd1 816 spd1 816 spd1 816
name size (bp) name size (bp) name size (bp) name size (bp)
sdA N/A sdA 981 sdA N/A sdA 981
2 genes
1-2 genes
C5a peptidase
Secreted Endo-beta-N-
acetylglucosaminidase 
Streptococcal inhibitor of 
complement
Streptodornase B*
Streptodornase D*
Fibronectin binding protein (FBP)
Collagen like surface protein (SclB)
Hyaluronan synthase (HasA)
Streptokinase
Exotoxins Cytolysin-cfa Factor
SP5
SP6 SP7 SP8 SP10
JI1
M protein
JI2
Hyaluronate lyase precursor*
JI3 SP4
M protein
Streptokinase
Exotoxins Cytolysin-cfa Factor
Hyaluronate lyase precursor*
C5a peptidase
Streptodornase B*
Secreted Endo-beta-N-
acetylglucosaminidase 
Streptococcal inhibitor of 
complement
Streptodornase D*
3-6 genes
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The FCT region organization was determined through manually examining the gene 
locus in question and comparing it with similar loci on the sequenced isolates and on 
known reference strains. The locus extends between two fixed genes; a chaperon 
encoding gene, and a hypothetical protein encoding gene. Among the nine FCT types 
characterized to date, the gene organization of our isolates conform mainly to FCT-3 and 
FCT-1 (Figure 7). Additional putative genes were detected as part of the locus and these 
were mainly encoding sortases and signal peptidases. 
 
Figure 8: Fibronectin-collagen-T-antigen (FCT) region organization of FCT types 1 and 
3. FCT-1 (JI8) was identified in only one of the isolates whereas FCT-3 was seen in all of 
the rest. The region is flanked by a chaperon (hsp33) and a hypothetical protein (hyp). In 
between are mostly cell wall-anchored proteins namely fibronectin binding proteins (fpb 
namely prtF1/2) and collagen binding proteins (cfa). Sortases (sort) that modify surface 
proteins are also found in addition to signal peptidases (sip). A combination of unique, 
highly diverse, and highly conserved loci determines the FCT type. 
In all, seven distinct Sag profiles were detected, with SpeBGKZ SpeBGJZ being the two 
most prevalent. Spe encoding genes were found to be mostly conserved amongst all the 
isolate. SpeH and SpeM were not detected on the sequenced genomes, while SpeB, SpeC, 
SpeG, and SmeZ were present in all of the isolates (Table 4). Interestingly, the majority 
of the superantigens are phage encoded, another feature of the highly dynamic S. 
pyogenes genome playing an important role in gene transfer and the enhancement 
pathogenicity in the species. 
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Table 4: Genes encoding the streptococcal superantigens found on the S. pyogenes 
genomes with their respective sizes. *phage-encoded elements, while the rest are 
chromosomally encoded. 
 
4.4. Antimicrobial resistance 
All the isolates were found to have resistance against macrolides through the presence of 
the DNA gyrase A and B encoding genes in addition to the topoisomerase B and C 
subunits encoded on the genome. Resistance mechanism against macrolides within all the 
sequenced genomes was mainly through the presence of an ABC transporter membrane-
spanning permease. Additionally, Multidrug resistance efflux pump, PmrA, was detected 
on all the genomes. In contrast, tetracycline resistance was seen only in two isolates, JI7 
and JI8, mediated through genes encoding the translation elongation factor G and the 
Factor
name size (bp) name size (bp) name size (bp) name size (bp) name size (bp)
speA N/A speA N/A speA N/A speA N/A speA 756
name size (bp) name size (bp) name size (bp) name size (bp) name size (bp)
speB 1197 speB 1197 speB 1197 speB 1197 speB 1197
name size (bp) name size (bp) name size (bp) name size (bp) name size (bp)
speC N/A speC N/A speC N/A speC N/A speC N/A
name size (bp) name size (bp) name size (bp) name size (bp) name size (bp)
speG 705 speG 705 speG 705 speG 705 speG 705
name size (bp) name size (bp) name size (bp) name size (bp) name size (bp)
speI 780 speI N/A speI N/A speI N/A speI N/A
name size (bp) name size (bp) name size (bp) name size (bp) name size (bp)
speJ N/A speJ N/A speJ N/A speJ 699 speJ 699
exosortase 207
name size (bp) name size (bp) name size (bp) name size (bp) name size (bp)
speK 708 speK 714 speK 708 speK N/A speK N/A
name size (bp) name size (bp) name size (bp) name size (bp) name size (bp)
speL N/A speL 789 speL N/A speL N/A speL N/A
name size (bp) name size (bp) name size (bp) name size (bp) name size (bp)
ssa 783 ssa N/A ssa N/A ssa N/A ssa N/A
name size (bp) name size (bp) name size (bp) name size (bp) name size (bp)
smeZ 702 smeZ 702 smeZ 702 smeZ 702 smeZ 702
exosortase 711
Factor
name size (bp) name size (bp) name size (bp) name size (bp)
speA N/A speA N/A speA N/A speA N/A
name size (bp) name size (bp) name size (bp) name size (bp)
speB 1197 speB 1197 speB 1197 speB 1197
name size (bp) name size (bp) name size (bp) name size (bp)
speC N/A speC 708 speC N/A speC N/A
name size (bp) name size (bp) name size (bp) name size (bp)
speG 705 speG 705 speG 705 speG 705
name size (bp) name size (bp) name size (bp) name size (bp)
speI N/A speI N/A speI 780 speI N/A
name size (bp) name size (bp) name size (bp) name size (bp)
speJ N/A speJ N/A speJ N/A speJ N/A
name size (bp) name size (bp) name size (bp) name size (bp)
speK 708 speK 780 speK N/A speK 708
name size (bp) name size (bp) name size (bp) name size (bp)
speL N/A speL N/A speL N/A speL N/A
name size (bp) name size (bp) name size (bp) name size (bp)
ssa N/A ssa 783 ssa 783 ssa N/A
name size (bp) name size (bp) name size (bp) name size (bp)
smeZ 702 smeZ 702 smeZ 702 smeZ 702
Streptococcal pyrogenic exotoxin L*
Streptococcal superantigen A*
Streptococcal mitogenic exotoxin Z
SP6 SP7
Streptococcal pyrogenic exotoxin J
Streptococcal pyrogenic exotoxin K*
SP8 SP10
Streptococcal pyrogenic exotoxin A*
Streptococcal pyrogenic exotoxin G
SP5JI1 JI2
Streptococcal pyrogenic exotoxin A*
Streptococcal pyrogenic exotoxin B
Streptococcal pyrogenic exotoxin C*
JI3 SP4
Streptococcal pyrogenic exotoxin I*
Streptococcal pyrogenic exotoxin J
Streptococcal pyrogenic exotoxin L*
Streptococcal superantigen A*
Streptococcal pyrogenic exotoxin K*
Streptococcal pyrogenic exotoxin I*
Streptococcal pyrogenic exotoxin G
Streptococcal mitogenic exotoxin Z
Streptococcal pyrogenic exotoxin B
Streptococcal pyrogenic exotoxin C*
37 
 
tetracycline resistance protein, TetM.  Interestingly, a multi antimicrobial extrusion MDR 
efflux pump, was also identified in those two isolates as well (Table 5). 
Table 5: Antimicrobial resistance proteins encoded on the S. pyogenes genomes. 
Antimicrobial Resistance Isolate 
Fluoroquinolones  
DNA gyrase subunit A JI1, JI2, JI3, JI4, JI5, JI6, JI7, JI8, JI10 
DNA gyrase subunit B JI1, JI2, JI3, JI4, JI5, JI6, JI7, JI8, JI10 
Topoisomerase IV subunit B JI1, JI2, JI3, JI4, JI5, JI6, JI7, JI8, JI10 
Topoisomerase IV subunit C JI1, JI2, JI3, JI4, JI5, JI6, JI7, JI8, JI10 
Macrolides  
ABC transporter membrane-spanning permease JI1, JI2, JI3, JI4, JI5, JI6, JI7, JI8, JI10 
Tetracycline resistance  
Translation elongation factor G JI7, JI8 
Tetracycline resistance protein TetM JI7, JI8 
MDR  Efflux Pump  
Multidrug resistance efflux pump PmrA JI1, JI2, JI3, JI4, JI5, JI6, JI7, JI8, JI10 
Multi antimicrobial extrusion protein 
(Na(+)/drug antiporter), MATE family of MDR 
efflux pumps 
JI7, JI8 
 
4.5. Phages and mobile elements 
Multiple phages were identified in the sequenced isolates (Table 6), the majority 
belonging to the ф315.x family of streptococcal phages. Other non-streptococcal phages 
were also identified such as phages from Enterococcus and Bacillus. On average, the 
phages were 42 Kbp in length and had a % GC content of 38 mol% and housed 64 coding 
sequences. 
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Table 6: Identity of putative phages and phage elements detected on the S. pyogenes 
genomes.* indicates Streptococcal specific phages, ∆ indicates confirmed complete phage 
sequences.  
 PHAGE NAME POSITION NO. OF 
CDS 
SIZE 
(KBP) 
GC % 
JI1 P9 Phage* 543481-587686 58 44.2  39.5% 
ф315.2*∆ 1235237-1280343  59  45.1 38.6% 
ф315.2* 1753586-1838804  104  85.2 37.8%  
ф315.2*∆ 1836641-1850391  22  13.7 39.2%  
Temperate phage 
фNIH1.1*∆ 
1856910-1921492  85  64.5 39.0%  
JI2 ф315.2*∆ 36431-86156 70 49.7 36.9% 
JI3 Enterococcus phage EFC-1 826891-851153  24  24.2 38.9%  
Bacillus phage Grass 1229568-1251639  22  22 39.7%  
ф315.4* 1702210-1746332  58  44.1 39.4%  
JI4 Enterococcus phage EFC-1 1051712-1083210  27  31.4  36.8%  
ф315.6*∆ 1157140-1191141  45  34  39.2%  
ф315.2* 1678710-1710884  35  32.1  35.7%  
ф315.4*∆ 1815357-1861474  56  46.1  39.3%  
Temperate phage 
фNIH1.1*∆ 
1865571-1906405  36  40.8  39.7%  
JI5 ф315.3* 814075-836688  32  22.6  37.6%  
ф315.3* 940132-963402  31  23.2  38.5%  
P9 Phage*∆ 1206221-1259975  65  53.7  39.6%  
ф315.2* 1658995-1687543  24  28.5  36.3%  
JI6 Temperate phage 
фNIH1.1* 
485708-527064  52  41.3  39.0%  
Bacillus phage G 1041449-1074731  19  33.2  39.5%  
Shigella phage SfIV 1723507-1733053  11  9.5  42.1%  
JI7 ф315.6*∆ 1113085-1154775  56  41.6  38.5%  
ф315.3* 1539782-1557690  27  17.9  36.4%  
ф315.4*∆ 1596065-1609564  22  13.5  36.7%  
Bacillus phage BCJA1c 1773969-1809715  32  35.7  35.8%  
ф315.4* 1804621-1885835  105  81.2  38.7%  
Bacillus phage G 1894717-1910959  25  16.2  42.2%  
JI8 Temperate phage 
фNIH1.1* 
580207-619535  53  39.3  38.3%  
ф315.2*∆ 1683466-1730855  68  47.3  38.0%  
P9 Phage* 1880672-1891879  23  11.2  40.0%  
JI10 ф315.3*∆ 1401342-1434194 47  32.8 37.8%  
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4.6. CRISPR detection 
Table 7: CRISPR loci detected on the streptococcal genomes with their associated Cas 
encoding genes. Cas types are also shown in addition to the length of the CRISPR locus 
and the number of spacers present. Note additional putative loci have been detected, 
however only the confirmed ones are outlined in this table. 
ISOLATE CRISPR GENES PRODUCTS LENGTH (BP) 
TYPE
(S) 
NO. OF 
SPACERS 
JI1 Cas1, Cas2, Cas3, Csd1, Csd2, Cas5d, Csn1, Csn2 228 I, IIA 3 
JI2 Cas1, Cas2, Csn1, Csn2 365 IIA 5 
JI3 Cas1, Cas2, Cas3, Csd1, Csd2, Cas5d, Csn1, Csn2 300 I, IIA 5 
JI4 Cas1, Cas2, Cas3, Csd1, Csd2, Cas5d, Csn1, Csn2 300 I, IIA 4 
JI5 Cas1, Cas2, Cas3, Csd1, Csd2, Cas5d, Csn1, Csn2 294 I, IIA 3 
JI6 Cas1, Cas2, Cas3, Csd1, Csd2, Cas5d, Csn1, Csn2 300 I, IIA 4 
JI7 - - - - 
JI8 Cas1, Cas2, Csn1, Csn2 299 IIA 4 
JI10 Cas1, Cas2, Cas3, Csd1, Csd2, Cas5d, Csn1, Csn2 
823 
 I, IIA 12 
 
4.7. Phylogenetic tree 
30658 SNPs were generated based on reference mapping of the sequenced genomes 
along with five reference strains; A20, M1GAS SF370, NZ131, MGAS6180, and MFAS 
10394.  These were then used for the construction of a rooted maximum parsimony 
phylogenetic tree. The isolates were distributed amongst three main clusters and sub-
clusters (Figure 9). The isolates were found to be non-clonal, and most of the ones 
clustering together had similar emm and/or MLST types such as JI5, JI4, JI3, and JI6. JI5 
clustered very closely to the emm1/ST-28 reference strains A20 and M1GAS SF370, with 
JI10 also joining the same cluster. In turn JI4 clustered with the reference strain 
MGAS6180 of same emm and MLST type. JI3 and JI6 were also phylogenetically close 
as well as both being emm89/ST-101. Some isolates clustered with strains of different 
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clones namely isolates JI7, JI10 and JI2; this is largely due to genomic recombination 
events and the introduction of novel genetic elements by phages. 
 
Figure 9: Phylogeny of the isolates based on SNP analysis. A rooted maximum 
parsimony SNP-based phylogenetic tree including the nine isolates along with five 
reference strains. Three main clusters can be seen with an even distribution of the isolates 
between cluster 1, and 2 and 3 together. Cluster 1 is further divided into three secondary 
clusters a, b, and c. The scale bar represents the number of base substitution per site.  
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Chapter Five 
DISCUSSION 
5.1. General genome features 
The sequenced genomes had an average size of 1.83 Mbp and an average G+C content of 
38 mol% both values falling in the general ranges for the organism (Wong et al., 2012). 
An average of 1,844 ORFs were found, covering 85% of the whole sequences with a 
calculated average size of 868 bp (Table 1). All of these features are consistent with the 
averages of each of their counterparts found on the respective reference strains of this 
study, and amongst S. pyogenes strains in general (NCBI, 2015). An average of 315 
functional subsystems were identified in the isolates (Figure 3). Protein-coding sequences 
distributed amongst the genomes include all the requisites for a glycolytic pathway, 
carbohydrate metabolism, fatty acid synthesis, and nucleotide synthesis. However, only 
nine amino acid synthesis subsystems were identified on the genomes, this reflects the 
fastidious growth requirements of S. pyogenes (Ferretti et al., 2001). The inherent lack 
biosynthetic pathways however, is offset by the relative abundance of membrane 
transport systems (37 subsystems) - that scavenge resources from the environment - 
including around 10 putative ABC transporters, used specifically for peptide uptake. On 
average 10% of the genome carried virulence factors and defense mechanisms, with 
another equal percentage dedicated to cell wall and capsule proteins. Given the small size 
of the streptococcal genomes, virulence related genes take up a significant part, this 
stresses on the importance of such elements for the success of S. pyogenes as a strict 
human pathogen (Cunningham, 2000). MLST is a sequence-based method useful for 
tracing genetic relations between isolates. In this study, the generated MLST types and 
their relationship with their respective emm types (Table 2) (Bahnan et al., 2014) were 
found to be conformant with global findings (Enright et al., 2001; McGregor et al., 2004). 
MLST types also revealed that most of the clones originate from the United States 
(Enright et al., 2001; McGregor et al., 2004). It is noteworthy that the detected 
combinations of MLST clones and emm types are mostly associated with upper 
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respiratory tract and skin infections with some reported as being invasive (Enright et al., 
2001; McMillan et al. 2013).  
5.2. Regulation, signaling, and stress response 
In bacteria, the number of σ factors present differs considerably between species. Up to 
18 σ factors can be present in Bacillus spp. down to only three factors found in 
Haemophilus influenzae (Kunst et al., 1997). The major σ factor in S. pyogenes and that 
was evidently identified in our streptococcal genomes was σ70 (ropD). Additionally, the 
ComX σ factor was identifiable in all of the isolates encoded by two distinct genes. The 
ComX is a homologue of the σ factor present in S. pneumoniae. This factor 
transcriptionally regulates competence specific genes serving in DNA uptake and 
integration (Luo & Morrison, 2003), and is encoded by two ORFs (Opdyke et al., 2001). 
Sequences of another probable σ factor were found in some of the genomes, these could 
be linked to a minor σ factor, σ24; a heat-competence transcriptional regulator homologue 
found in Escherichia coli (Las Peñas et al., 1997). S. pyogenes might have evolutionarily 
developed this factor as the organism regularly encounters high temperatures inside the 
human host (Ferretti et al., 2001). Overall, three to four σ factors have been identified in 
our genomes, a number that falls within the range of σ factors found in small bacterial 
genomes (1-4 σ factors) (Feklistov et al., 2014).  
Similar to other organisms, the choice of transcription signals in S pyogenes, allows the 
organism to respond to changes in its environment (Feklistov et al., 2014). Additionally, 
S. pyogenes possesses a number of stress response proteins, namely proteases and highly 
conserved stress regulation genes (Ferretti et al., 2001). A system for osmoregulation 
composed of aquaporin Z and osmotically inducible outer membrane proteins (ompA, 
osmY) was detected in all the genomes. A complementary system of choline and betaine 
uptake biosynthesis was also detected. These genes are highly conserved among bacterial 
species and encode proteins that can serve as both osmoprotectants and energy sources 
(Wargo et al., 2008). With respect to acid stress response, it is most likely mediated 
through proton translocation via the FoF1 ATP synthase as with other lactic acid 
producing streptococcal species (Suzuki et al., 2000). Eight genes encoding structural 
parts of FoF1 ATP synthase were found on the genomes. Cold and heat shock response 
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proteins were also identified as part of the genomes. The main gene products detected 
were the Csp family of proteins, namely CspA, responsible for the cold stress response. 
This protein family counteracts the detrimental effects of a downshift in temperature the 
bacterium might face (Phadtare, 2004). With respect to its counterpart, the heat shock 
response family of proteins was detected as part of the DnaK gene cluster. This cluster 
houses a variety of protein families such as ribosomal methyltransferases, and chaperones 
(DnaJ, DnaK), amongst others. The DnaK gene cluster is still poorly characterized in 
streptococci, however it is known to be a highly conserved locus among firmicutes 
(Homuth et al., 1997). The resulting gene products function mainly in preventing heat 
denatured proteins from aggregating inside the cell as a result of heat shock (Takaya et 
al., 2004). Interestingly, instances of activation of such gene cluster have been reported in 
some species (Salmonella enterica) inside macrophages, during an active infection 
(Takaya et al., 2004), a fact that may hint at their possible involvement in pathogenesis. 
Accordingly, the heterogeneity of stress response elements present on the streptococcal 
genome allows S. pyogenes to dynamically resist harsh conditions that might arise, 
whether inside or outside the host. Although some of these systems are still poorly 
studied in the species itself, comparative studies could illustrate their function in bacterial 
proliferation and possibly host pathogenesis. 
Gene regulation in S. pyogenes species is under strict control, manifested through the 
actions of several regulatory systems. This stringent gene control, mainly in response to 
environmental changes, has shown to mediate the development of infections from 
superficial to invasive (Sumby et al., 2006). To date, genome analysis studies have 
characterized around 13 two-component regulatory systems in S. pyogenes, with more 
than a 100 possible independent transcriptional regulators (Musser & Shelburne, 2009; 
Walker et al., 2014). Perhaps one of the most important regulons to be discussed and that 
was found on all the sequenced genomes in this study, is the control of virulence 
regulatory system (covRS). Also referred to as the capsule synthesis regulon (csrRS), this 
regulation element is made up of two components; a membrane-bound sensor kinase 
(CovS), and a DNA binding response regulator (CovR) (Dalton & Scott, 2004). In its 
basic mode of action, the covRS regulon controls streptococcal virulence in response to 
environmental conditions such as pH, temperature, and ion concentrations (Walker et al., 
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2014). The covRS regulon controls the expression of around 10 to 15% of the 
streptococcal genes either directly or indirectly (Trevino et al., 2009). Another feature of 
the regulon is that it positively modulates the expression of streptococcal pyrogenic 
exotoxin SpeB, and the hyaluronic acid capsule synthesis, amongst other virulence 
factors (Sumby et al., 2006). Unidirectional mutations in the covRS regulon have proven 
to alter the expression of virulence factors and alter the progression of GAS invasive 
diseases (Walker et al., 2007). Another important regulon present on the genomes, is the 
multiple-gene regulator (mga). This system controls the expression of numerous 
virulence genes, including the M family of proteins, and its activity has been linked to 
carbohydrate availability in the environment (Ribardo & McIver, 2006). This mechanism 
is very critical for the organism when shifting from the colonization stages to deep tissue 
invasion (Hondorp et al., 2013). In murine models of GAS infections, the inhibition of 
the Mga regulon, has shown to impair the initiation of invasive diseases (Hondorp et al., 
2013), highlighting the regulon’s ability to modulate streptococcal diseases. 
Conclusively, the presence of multiple gene regulation systems on the genomes, and the 
strict regulation of virulence factors by these systems as a function of environmental 
conditions, outlines S. pyogenes infections as being a highly transitional event closely 
linked to external stimuli in the host. 
5.3. Virulence factors  
An abundance of the genes making up the streptococcal virulome was detected in all of 
the sequenced genomes (Table 3). Most of these elements are found scattered throughout 
the genome and are not strictly part of a pathogenicity island (Feretti et al., 2001). 
Additionally, their majority is normally conserved in the species except for the ones 
encoded by phages and prophages (Inagaki et al., 2000). The genes coding for exotoxin 
cytolysins such as the streptokinase, hyaluronate lyase, and nicotine adenine dinucleotide 
glycohydrolase (NADGH) were found to be highly conserved amongst all isolates. These 
cytolysins promote pathogenesis in the host by inducing apoptosis in neutrophils and 
macrophages (Walker et al., 2014). It was interesting to find the cyclic AMP (CAMP) 
factor gene cfa in all of the isolates sequenced in this study, as it was originally thought to 
be exclusive to Group B Streptococci (GBS) (Gase et al., 1999), however it started to be 
45 
 
identified in GAS since the original sequencing work of Feretti et al., (2001). The cfa 
gene product is an extracellular protein that causes synergistic lysis of host erythrocytes. 
The reaction was first described by Christie et al. and seen in Staphylococcus aureus 
isolates (Christie et al., 1944), and later fully characterized as belonging to GBS 
(Podbielski et al., 1994). The role of CAMP factor in pathogenesis is not yet clearly 
understood. However, its importance here lies in the impeccable homology seen between 
the genes found in all of our sequenced isolates, highlighting the possibility of successful 
horizontal gene transfer (HGT) between streptococci. Many of the related streptococcal 
species are naturally competent, and can undergo successful transformation via a pathway 
yet to be described (Feretti et al., 2001), which has led us to speculate that the presence of 
the cfa gene could be attributed to mobilization. 
The plasminogen receptor was detected in all the isolates in this study, while the GAPDH 
gene was found present in only four of the isolates, and absent within the selected 
reference strains. Other strains such as MGAS9429 and MGAS10270 were found to have 
the GAPDH gene, whereas the plasminogen receptor is more widespread in other GAS 
species, namely Streptococcus pneumoniae (Attali et al., 2008). Genes coding for the 
leukocidins streptolysin S and streptolysin O, were present in all the isolates. SLO is an 
oxygen-labile hemolysin, it acts in disrupting host cell membranes and induces apoptosis 
in phagocytic cells (Timmer et al., 2009). Genes encoding SLS were found part of a nine 
gene operon; sagA through sagI. SLS is virtually secreted by all GAS (Nizet et al., 2000), 
it increases bacterial cell resistance to phagocytosis by disrupting neutrophil membranes 
(Miyoshi-Akiyama et al., 2005), additionally, SLS has the ability to lyse many host cell 
types, namely erythrocytes, lymphocytes, and even platelets (Ofek et al., 1972). Both 
SLO and SLS massively contribute to the rapid tissue necrosis characteristic of invasive 
diseases, and their expression enhances streptococcal pathogenesis as a whole (Walker et 
al., 2014). The presence of genetic elements in some S. pyogenes strains but not others, 
can only be attributed to the acquisition of exogenous genetic elements between GAS 
strains either through HGT, or through bacteriophages (Beres & Musser, 2007). The sic 
gene was found present only in isolate JI5 which was previously typed as emm1 
(Bahanan et al., 2010), and in the M1 GAS reference strain. This gene is characteristic of 
M1 GAS and M57 GAS strains only (Akesson et al.,), and does in fact confirm the work 
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done by Bahnan et al. (2010). The SIC is a very important virulence factor that binds and 
inhibits the complement component C5b, and by that inhibiting the formation of the 
MAC (Fernie-King, et al., 2001). SIC also aids in cell adhesion, colonization, and 
inactivation of human innate immune factors (Lukomski et al., 2000; Hoe et al., 2001). 
High polymorphism is usually seen in the sic gene, mostly due to a strong immune 
pressure exerted by host neutralizing antibodies, leading to a large variation in the sic  
alleles within the same emm type (Hoe et al., 2001), however this is not the case here, as 
both genes form JI5 and M1 GAS showed sequence homology. 
Another element found amongst all the isolates is the 3 Kbp ndoS gene, encoding the 
secreted endo-beta-N-acetylglucosaminidase of streptococci, EndoS. EndoS is an 
immunoglobulin degrading enzyme that plays a crucial role in helping the microorganism 
resist opsonophagocytosis, inevitably intensifying pathogenicity towards the host 
(Walker et al., 2014). This gene had some size differences tracing back to possible 
insertions or deletions in the sequence. After individual BLASTing of the sequences, the 
protein product hits were spread evenly between the two isoforms EndoS and EndoS F2, 
which are similar enzymes differing only in their oligosaccharide specificity (Plummer & 
Tarentino, 1991) but both being far from the EndoS2 form isolated in serotype M49 GAS 
only (Sijogren et al., 2013), a fact that confirms that none of the isolates are emm49 as 
typed earlier on (Bahnan et al., 2010). The heterologous expression of the EndoS in GAS 
strains, other than the M1 serotype however, should not be easily dismissed, as it has 
been shown to enhance virulence in murine models of invasive streptococcal infections 
(Sjorgen et al., 2011). 
Genes encoding the exotoxin nuclease streptodornase B were present in all of the 
sequenced isolates in this study as well as in the reference strains. These elements were 
conserved in size and in location on the bacterial genome, and were found part of an 
extended SpeB-SpeF regulon and flanked by a transcriptional regulator and a low 
temperature response protein. High sequence homology was found between the genes in 
questions and their counterparts on bacteriophages, namely on the S. pyogenes phages 
315.3, 315.6, and phage 9. Even though such genes were traditionally encoded on 
bacteriophages (Aziz et al., 2004), the uniformity of their location on the bacterial 
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genomes suggests that they have become fixed remnants of phage integration events over 
time. Additionally, the Sda gene, a 981 bp fragment encoding the streptodornase B 
nuclease, was detected in two thirds of the isolates. Sda, which is also encoded on phages 
315.3 and 315.6, was not found in any of the proposed references but rather in 
MGAS5005 and MGAS9429 strains, further reinforcing the theory of acquiring foreign 
genetic material through HGT. A varied assortment of genes encoding mitogenic factors 
was also found on the genomes ranging from 1 to 3 such genes per isolate. Additionally, 
among the exotoxins strictly conserved in all isolates was the immunoglobulin-binding 
protease IdeS. All of the gene products detected were of the isoform Mac-1 and none 
were of the related Mac-2 isoform (Agniswamy et al., 2004). Although IdeS is a potent 
protein in impairing neutrophil mediated phagocytosis (Lei et al., 2001), it is not an 
essential one for phagocyte resistance (Okumura et al., 2013), a fact that might explain 
the lack of an evolutionary stress to drive diversity among products of this gene in 
particular.  
Furthermore, a large number of fibronectin binding proteins was detected in all of the 
studied isolates, ranging from three to nine protein encoding genes as was seen in JI7, in 
addition to numerous collagen-like surface proteins (SclA and SclB). BLAST results of 
the respective amino acid sequences showed overall homology but with minor 
differences, which mostly contribute to the different characteristics of these genes in 
different emm types (Nakagawa et al., 2003). These results conform to the findings of 
Caswell et al. (2008; 2010). The genes encoding fibronectin binding proteins are found 
arranged in clusters as a pathogenicity island located in the FCT region of the genome, 
this was repeatedly reported as being a hot intergenomic recombination site (Bessen & 
Kalia, 2002), with reports of nine distinct variants (Kratovac et al., 2007). Three major 
locations for fibronectin binding proteins were found on the streptococcal genome; one 
gene was found to be downstream of the C5a peptidase encoding gene, another set (two 
to three genes) was found downstream of the streptopain/streptopain inhibitor set of 
genes, and the final location was in the FCT region. Not all of the isolates carried those 
genes in all of the three indicated locations but all of them had fibronectin binding 
proteins gene in the FCT region. All the isolates had the FCT-3 arrangement previously 
described by Kratovac, while only JI8 had an FCT-1 layout (Kratovac et al., 2007). The 
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FCT region is a ≈11 to 16 Kbp chromosomal region flanked by highly conserved genes, a 
chaperon and a hypothetical protein, between which a unique combination of conserved 
and semi-conserved loci was present (Bessen & Kalia, 2002; Kratovac et al., 2007), an 
aspect clearly detected in this study (Figure 8). Medically, fibrinogen binding proteins aid 
in the adhesion of S. pyogenes cells to the host, and confer resistance to phagocytosis by 
preventing the C3 convertase from depositing on the bacterial cell (Hortsmann et al., 
1988). These proteins play an essential role in the pathogenesis of S. pyogenes. Mutations 
targeting those proteins were associated with a decrease in the epithelial cell adhesion 
efficiency by up to 10% in murine models (Schulze et al., 2006; Lizano et al., 2007). 
Additionally, even GAS strains that do not express high-affinity plasminogen binding 
proteins, but have fibrinogen binding proteins instead can still activate plasminogen-
mediated virulence through a stable cell-associated enzymatic activity that lyses fibrin 
clots (Wang et al., 1995). prtF1 was detected in all of the isolates, while cpa only in some 
of them. These findings are in harmony with those reported by Kratovac et al., and the 
presence of both gene products could prime skin and throat infections (Kratovac et al., 
2007), as is the case with the isolates undertaken in this study. The FCT region is a high 
recombinatorial zone on the streptococcal genome. This is mainly due to the strong 
selective pressure for change in response to the harsh conditions within the host (Bessen 
& Kalia, 2002), which again highlights the adaptability of S. pyogenes, pathogen tailored 
for human infections (Cunningham, 2000).  
Interestingly, the scpA gene encoding the bacterial C5a peptidase, was also well 
conserved among all isolates with a size of around 3550 bp, and found strictly as part of 
the mga regulon (Chen & Cleary, 1990). As mentioned previously, this peptidase is vital 
to the pathogenicity of GAS infections, however the absence of any genetic variation in 
this element indicates that its involvement in severe GAS infections may be due to a 
regulation in gene expression and not in the gene itself (Cunningham 2000). 
Coincidentally, the region that extends from the smeZ gene through the mf1 gene, to the 
mga regulon, considered to be a pathogenicity island, is one of the best studied regions in 
the streptococcal genome for its virulence factors and their associated regulatory genes 
(Ferreti et al., 2001). The mga regulon is an independent, ubiquitous, multiple-gene 
regulator that governs the transcription of a variety of virulence genes most importantly 
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those encoding the M family proteins (emm, mrp, arp, and enn). These play a significant 
part in streptococcal adhesion, invasion, and host immune evasion (Ribardo & McIver, 
2006; Hondorp & McIver, 2007). The mga regulon associated regions detected in this 
work showed high variability in genetic content; the regions included multiple M protein 
and the C5a peptidase encoding genes. BLASTing the individual gene sequences 
revealed the presence of the emm gene in all and a fibronectin binding protein in six of 
the sequenced isolates as well as in the MGAS6180 reference strain. An immunoglobulin 
A receptor was also found in six of the isolates. JI6 showed the additional presence of the 
ennX gene in the operon, and was found homologous to that present in the reference 
strain NZ131. BLASTing of the emm genes successfully identified the M-types of the 
isolates (Table 2), which was in harmony with previous results (Bahnan et al., 2011). 
Overall, the regulon layout present in the isolates showed highest homology with the one 
found in MGAS6180.  The mga regulon is extremely important for bacterial 
pathogenesis, as it also regulates the expression of other non M protein family genes such 
as complement inhibitors (sic, scpA) and collagen-like surface proteins (sclA) (McIver et 
al., 1995). Moreover, it solely controls the expression of about 10% of the streptococcal 
genome (Hondorp & McIver, 2007). The genetic diversity found amongst the genes 
coding for adhesins in this study was similar to previous findings (Feretti et al., 2001; 
Nakagawa et al., 2003; Hondrop & McIver, 2007). The layout of the genes in the mga 
regulon, and its diversity, correlates with both tissue tropism and disease manifestation 
(Nakagawa et al., 2003; Hondrop & McIver, 2007). Commonly, S. pyogenes strains 
presenting one M family protein are limited to throat infections, and those that present 
three or more proteins are involved in more invasive diseases (Hollingshead et al., 1993). 
Seven out of the nine isolates presented in this study have been detected with multiple M 
family protein genes, and even though the majority of these strains have been isolated 
from pharyngitis cases, their genomic M protein content, indicates that if left to 
propagate, such streptococci can develop more serious infections. 
Superantigens are considered by many to be more important than emm types in disease 
substantiation (Rantala et al., 2012). Superantigens are perhaps the most notorious of all 
the streptococcal antigens (Spaulding et al., 2013), which can be mainly attributed to their 
ability to overstimulate the human immune system and cause life-threatening infections 
50 
 
such as myositis, necrotizing fasciitis, and STSS (Stevens et al., 1989).  All superantigens 
are encoded on phages with the exception of SpeG and SmeZ which are chromosomally 
encoded (Commons et al., 2014). WGS revealed that all the isolates undertaken in this 
study along with the reference strains had the genes encoding the superantigens SpeG and 
SmeZ. Differences however are seen, in the phage associated SAg; SpeB was found in all 
of the isolates, SpeK in two thirds and in MGAS6180 reference strain, and SSA detected 
in one third of the isolates. These findings are consistent with the worldwide 
dissemination of S. pyogenes clones (Commons et al., 2008) and with previous studies 
done in the region (Karaky et al., 2014). SpeA, SpeC, and SpeL were found in JI5, JI7, 
and JI2, respectively. Hence, seven distinct Sag profiles were detected, with SpeBGKZ 
and SpeBGJZ being the two most prevalent (four out of nine cumulatively). Two SAg 
profiles matched the two emm types 12 and 89, which are mostly associated with 
puerperal sepsis and cellulitis (Luca-Harari et al., 2009). It is noteworthy, that isolate JI5 
of emm type 1 was the only isolate in which SpeA was detected, a characteristic unique to 
emm1 types and associated with severe infections such kidney failure (Luca-Harari et al., 
2008; Chan et al., 2009). SpeI, which has a very low occurrence, was found in only one 
of the isolates (JI8) along with SAgs B, G, Z and SSA. In contrast to previous work that 
advocated the co-occurrence of both SpeI and SpeH, being carried on the same 
bacteriophage (φ370.2) (Ferretti et al., 2001), our findings was in harmony with that of 
Commons et al. (2008) who reported that SpeI may have been lost during integration in 
the streptococcal genome, or that it was encoded by a gene carried on an entirely different 
phage, both of which can explain the reason behind the low prevalence of this SAg 
(Commons et al., 2008).  
5.4. Antimicrobial resistance 
Generally, streptococcal infections are manageable through the use of penicillin due to 
the lack of natural resistance in S. pyogenes (Imohl et al., 2010). However complications 
start to arise when patients are allergic to penicillin. (Walker et al., 2014). In such cases 
macrolides are given as an alternative treatment, which led to resistance either through 
efflux pumps (mefA) or through ribosomal methylases (erm) (Seppala et al., 1998). Genes 
encoding for any β-lactamases were not detected in any of the sequenced genomes in this 
51 
 
study (Table 5). Previous studies have reported an increasing macrolide resistance among 
S. pyogenes isolates in the region (Bahnan et al., 2010; Karaky et al., 2014), and our 
study further supports those findings. Macrolide resistance (10% - 23%) is much higher 
than the ones reported in many western European countries such as Germany (2.6%), 
Belgium (3.3%), and Spain (7.6%), where a restrictive use of macrolides was instituted 
(Farmand et al., 2012; Van Heirstraeten et al., 2012; Ardanuy et al., 2010). In all, our 
results conform to clinical antibigram studies previously carried out on these isolates 
(Karaky et al., 2014). However the use of antibiotics for the treatment of infections in 
Lebanon is still uncontrolled, and this might be one of the reasons behind the ongoing 
increase in resistance to certain antimicrobial agents.  
Fluoroquinolone resistance is another feature of GAS that has been reported by several 
studies (Wajima et al., 2008; Yan et al., 2008; Montes et al., 2010). Two types of 
resistance are observed, a low-level resistance, and a high level resistance which occurs 
much less frequently (Perez-Trallero et al., 2011). The former is conferred by mutations 
in the quinolone-resistance-determining region (QRDR) located within the topoisomerase 
IV, namely the parC and parE genes, while the latter is due to additional mutations in 
gyrA and gyrB genes of the DNA gyrase (Montes et al., 2010). In our study, all of the 
isolates showed high-level fluoroquinolone resistance, seen through mutations in the 
DNA gyrase A and B subunits (gyrA, gyrB) in addition to mutations in the topoisomerase 
IV B and C subunits (parC and parE). Additionally, a multidrug resistance pump (PmrA) 
mainly for the efflux of fluoroquinolones (Gill et al., 1999), was detected in all the 
isolates. These findings were in harmony with the global increase in fluoroquinolone 
resistance. In Belgium and Spain resistance rates rose from 4.3% and 1.9% to 21.6% and 
30.8% respectively, during a span of two to three years (Montes et al., 2010; Van 
Heirstraeten et al., 2012). However in contrast to these two studies, the sequenced 
isolates were not limited to a set of emm types. The acquisition of fluoroquinolone 
resistance has been attributed to spontaneous nucleotide mutations in the QRDR region or 
to HGT (Peltz et al., 2006), however in both cases the resulting clonal expansion of such 
isolates has led to a rapid increase in the prevalence of resistance in GAS in present years 
(Montes et al., 2010). The importance of these findings lay in the fact that new generation 
fluoroquinolones are being used as an effective alternate to penicillin in allergic patients, 
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the increasing emergence of a co-resistance pattern amongst GAS strains may present a 
big hurdle for successful treatment (Ardanuy et al., 2010).  
Tetracycline resistance is another feature seen in S. pyogenes strains, it is usually 
mediated through ribosomal protection genes such as tetM and tetO (Chopra & Roberts, 
2001). A homology exists between these gene products and the elongation factors EF-G 
and EF-Tu, where they displace tetracyline from the ribosome through an inherent 
GTPase activity (Li et al., 2013). Two of our nine isolates had tetracycline resistance 
genes on their genomes, namely tetM and EF-G, suggesting a multi-drug resistant 
European clone lineage (Mihaila-Amrouche et al., 2004). Although not very common 
amongst streptococci (Malhotra-Kumar et al., 2005), efflux pumps also confer 
tetracycline resistance, and one such element was detected in isolate JI7. This pump is a 
multi-antimicrobial extrusion protein (MATE) type efflux pump that exports tetracycline 
out of the streptococcal cell, possibly analogous to the one detected in S. aureus 
(Fionnuala McAleese et al., 2005). Notably, tetracycline encoding resistance genes are 
often associated with macrolide resistant genes on the same mobile element, hence the 
unregulated use of tetracyline and macrolides reciprocally augments resistance to both 
agents (Brenciani et al., 2010; Giovanetti et al., 2012).  
5.5. Bacteriophages, mobile elements and genomic recombination 
HGT is the driving force behind bacterial evolution and the acquisition of new genetic 
features. HGT plays a key role in conferring new properties to microorganisms allowing 
them to colonize new niches and to adapt their metabolic processes (Dobrindt et al., 
2010). The three HGT mechanisms are: conjugation, transduction, and transformation 
(Ochman et al., 2000). Often, transduction, via a bacteriophage leads to the most 
impacting alterations in Gram- positive bacterial genomes. The successful integration of a 
phage in the genome can transform a non-pathogenic bacterium into a pathogenic one, 
through toxins and/or resistance elements encoded by genes carried on the phage genome 
(Canchaya et al., 2004). S. pyogenes in particular, is known to have a highly dynamic 
genome, mainly due to the numerous prophage integration sites. The S. pyogenes genome 
can be littered with numerous phages and transposable elements, in fact such elements 
can account for around 7-14% of the total genome (Bisno et al., 2003) (Feretti et al., 
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2001). A large part of the S. pyogenes pathogenesis is derived from phage-encoded genes 
such as SpeB, SpeC, and SpE. Other exotoxins that are directly responsible for invasive 
diseases have also been found to be encoded by bacteriophages (Walker et al., 2014). 
Additionally, phages widely contribute to the diversity of S. pyogenes strains, as around 
90% of the S. pyogenes genomic content is shared even among different serotypes with 
the exclusion of the unique prophage sequences (Musser & DeLeo, 2005). In this context, 
de novo genome assemblies are needed to identify novel regions not found in the 
reference genomes. Several confirmed and putative prophages and prophage-like 
elements were detected in our study (Table 6). The most prominent phage types were the 
ф315.x family of S. pyogenes specific phages, and the P9 phages. These regions were 
found to encode streptodornases A and B in addition to a hyaluronidase, all of which are 
major virulence factors. It was noticed that the same set of prophages integrated at 
different positions in different genomes, reinforcing the fact that prophages contribute to 
the genomic rearrangements of the species (Nakagawa et al., 2003). Phage holin genes 
were also detected on the genomes namely in the ф315.x phages, such regions are known 
to be hot recombination sites between different prophages adding to the diversity that 
phages bring to the S. pyogenes genome (Nakagawa et al., 2003). It is interesting to note 
that the presence of similar phages on one particular genome is due to the fact that phage 
integration is an ongoing process; some of these elements might be remnants of old 
integration events (Green et al., 2005), while others may be due to new infections. Either 
way, even similar phages can house different gene sets, all of which actively contribute to 
the genetic diversity amongst S. pyogenes. Non species-specific phages were also 
detected, such as bacillus and enterococcus phages, these hint at the importance of phage 
DNA uptake as a way for S. pyogenes to propagate and thrive in the host. Given that S. 
pyogenes is a human restricted pathogen, the process through which these 
microorganisms have acquired phages originally, remains negotiable. This however, was 
previously attributed to the presence of small signaling molecules present in mammalian 
cells. Those act as phage inducers, only activating phage induction when the 
environmental conditions are best suited to accommodate competent recipient host 
organism such as S. pyogenes (Fischetti, 2007). In all, phage acquisition remains an 
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essential mechanism for the ability of GAS to survive in the human host and cause 
disease.   
5.6. CRISPRs 
Bacterial infection with a viral phage can have two different consequences. Phage 
infection may cause bacteriolysis (Mcgrath et al., 2007), and as a response to this 
inherent threat, bacteria have developed several defense systems to impede the 
integration of viral and plasmid DNA into their genome (Labrie et al., 2010). One such 
novel defense mechanism is the clustered regularly interspaced short palindromic repeats 
(CRISPR) loci (Brouns et al., 2008). Structurally, CRISPR loci are composed of a short 
repeat sequence interspaced by a unique variable sequence called spacer (Sorek et al., 
2008). The repeat sequence is well conserved while spacers are highly variable and have 
high sequence similarity to phage and plasmid DNA (Godde & Bickerton, 2006). 
Adjacent to the CRISPR locus are important components of the CRISPR system called 
CRISPR-associated (cas) genes (Stern et al. 2010). Functionally, the CRISPR/Cas system 
confers a form of acquired immunity for bacterial cells. The system acts in a two-step 
manner: first the foreign DNA is uptaken and integrated as a spacer in the CRISPR locus, 
followed by the targeting and cleavage of foreign DNA in a sequence specific manner. 
Cas operons of CRISPRs are classified into three main types (I, II, and III) having only 
two universally present genes, cas1 and cas2. Further classification into subtypes also 
exists, with each of the subtypes having a distinct cas protein (Sorek et al., 2013). S. 
pyogenes have been shown to house two CRISPR loci at most (Nozawa et al., 2011). In 
our study, CRISPR/cas systems were identified in all but one of the isolates (JI7). In 
accordance with a study by Nozawa and colleagues (Nozawa et al., 2011), two thirds of 
the genomes showed the presence of two CRISPR loci namely of cas types I and IIA 
(Deng et al., 2013), attributed to the presence of cas2, and cas3, respectively. Only two 
isolates, JI2 and JI8, had a single CRISPR locus of type IIA. The number of spacers 
detected in the systems is relatively low at three to five spacers per locus (except JI10 
which had a locus with 12 spacers). This indicates a lower CRISPR activity of the species 
relative to other streptococcal species, as spacer count is a good indicative of CRISPR 
activity (Touchon & Rocha, 2010). The relative scarcity of spacers in the loci suggests 
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that most of the spacers were deleted, and that the process of acquiring new spacers is a 
dynamic one, highly dependent on the Cas1 protein (Wiedenheft et al., 2009). 
Traditionally, spacer deletion is a way for bacteria to prevent the over-inflation of the 
CRISPR locus (Tyson & Banfield, 2008), a fact also seen in our isolates. However this 
lack of spacers and its irregularity might be attributed to spontaneous homologous 
recombination events in the S. pyogenes genome. Additionally, low number of spacers 
can be due to the fact that the CRISPR/cas system in this organism cannot efficiently 
acquire new spacers as other bacteria do (Nozawa et al., 2011). In the same work by 
Nozawa, an inverse relationship was shown to exist between the number of 
CRISPRs/spacers and prophages such that S. pyogenes strains with high CRISPR content 
more readily reject prophage integration, however the number of isolates in our study is 
relatively low to concur with these findings (Nozawa et al., 2011). CRISPR involvement 
in adaptation to the environment has been reported in enterococci (Kelli & Palmer, 2010), 
hence S. pyogenes may similarly have downgraded its CASPR/Cas activity to bolster its 
ability to acquire virulence genes especially in the human host. This phenomenon, in 
addition to the dynamic genome-wide recombination events, may contribute to the 
multiple strain-specific pathogenicities seen in S. pyogenes (Nozawa et al., 2011).  
5.7. Phylogeny 
WGS coupled with SNP analysis have been shown to have a high discriminatory power 
when dealing with closely related isolates, and have allowed for accurate epidemiological 
analysis (Lewis et al., 2010; Ben Zakour et al., 2012). After SNP analysis of the 
sequenced genomes, the isolates were ordered in three major and several sub-
phylogenetic clusters (Figure 9). JI5 of emm1 naturally clustered with the emm1 reference 
strains, A20 and M1GAS SF370. The very close clustering of JI5 with these reference is 
also reinforced by the fact that all three belong to the same clonal complex as well. 
Despite having different emm and MLST types, JI10 was part of the 1a cluster, this can 
be attributed to large genomic recombinations and HGT elements in its genome as 
discussed earlier. A20 is a Taiwanese clone while M1GAS SF370 is an American clone 
(NCBI, 2015), with JI5 being phylogenetically closer to the former, it might be of the 
same geographical origin as well. In this context, it is noteworthy that JI5 was clinically 
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isolated from a skin infection, and that sequencing detected the covRS system and the 
SpeB superantigen (Table 4) both intact on its genome. These findings are in full 
accordance with the original study characterizing the A20 strain (Zheng et al., 2013), a 
fact that most certainly shows a high similarity between our isolate and the Taiwanese 
A20. Additionally, isolate JI4 clustered closely with strain MGAS6180 indicative of their 
common emm and sequence types. It is very interesting to note that MGAS6180 is linked 
to puerperal sepsis, and that its virulence and pathogenesis are linked are linked to the 
acquisition of foreign genes (Green et al., 2005). Referring back to our findings (Tables 
3, 4, 5, and 6), they seem to agree with the presented facts and can clearly link JI4 to 
puerperal sepsis and other invasive diseases.  JI1 was also seen belonging to cluster 1c a 
fact linked to the multitude of phages detected on its genome and the genomic reshuffling 
they induce (Table 6). Being both clonal and of the same emm type, isolates JI3 and JI6 
clustered very closely together. Looking at their genomic content (Tables 3, 4, 5, and 6), 
we can see a very high similarity and this might explain their very close phylogenetic 
proximity as they might as well belong to the same strain. The genomic plasticity of S. 
pyogenes can be seen once again, with JI7 clustering with a completely clonally and 
serotypically different reference strain. It is worthy to note that this close clustering can 
be due the shared phage and prophage elements. Sequencing the MGAS10394 genome 
has shown the presence of eight prophage-like elements (Banks et al., 2004), a fact in 
agreement with our findings of six phage-related element at least on the JI7 genome 
(Table 6). JI7 was shown to be one of the few genomes to code for SpeA superantigen 
(Table 4), another characteristic of MGAS10394 (Banks et al., 2004). Additionally, 
MGAS10394 was originally isolated from the throat of a patient with pharyngitis, and 
found to be macrolide resistant (Banks et al., 2003), both of these features are conformant 
to our JI7 isolate (Table 5).  Conclusively, although all of our isolates are associated with 
pharyngitis and skin infections, their distinct clustering with different invasive strains, 
indicate their potential invasiveness. The isolates did not represent a single clone, and 
SNP-based phylogeny was able to discriminate between the isolates and to cluster them 
with their similar counterparts. 
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5.8. Importance of this study 
Overall, this study served as a powerful means for the successful identification and 
characterization of genome-wide determinants of S. pyogenes and their clinical and 
evolutionary outcomes. Through sequencing the whole streptococcal genome, we were 
able to take a closer look at the various functional systems present in the organism along 
with the respective regulation mechanisms. Moving on to more clinically relevant 
aspects, the wide array of streptococcal virulence factors were identified and correlated to 
the clinical manifestations of infections with such isolates. M proteins were also 
successfully characterized and linked to the potential of certain serotypes to initiate 
invasive infections. Superantigen profiles were generated showing several Spes present 
on the genomes, an indication of the possible severity of diseases caused by these isolates 
if left to propagate. Antimicrobial resistance mechanisms were also screened, and the 
isolates were found to confer resistance mostly to macrolides and tetracyclines, a fact that 
might hamper successful treatment when dealing with penicillin allergic patients. 
Inherently, the widespread presence of phages and mobile elements encoding virulence 
and resistance genes on the sequenced genomes, shed light on the large reliance of S. 
pyogenes on the uptake of foreign DNA for the initiation and propagation during human 
pathogenesis. Phage integration is a very important aspect of the S. pyogenes genomes; it 
enhances virulence and adds to the genetic diversity of the strains as phages are sources 
of novel genes and additional sites for genomic recombinations. The genomes were 
noticed to have a flexible architecture, largely due to genomic rearrangements attributed 
to both the multiplicity of phage integration events, and to the vigorous nature of the S. 
pyogenes genome in terms of spontaneous genomic recombination. These facts, coupled 
with the variation in genes sequences would lead to a large phylogenetic and evolutionary 
diversity of the species, even within similar serotypes. Such relations were clearly seen 
through SNP analysis and phylogeny of the assembled genomes. However due to the fast 
evolution of the species and its high genome plasticity, constant vigilance of the available 
clones and their tracking is essential to prevent outbreaks. CRISPRs were also detected 
and can be used as the basis of a new genetically engineered antimicrobial therapy to 
specifically target resistant or highly virulent clones. Further studies could include the 
correlation of the bacterial genomic features with patient clinical history and infection 
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systems. Furthermore, a robust system for identifying and tracking S. pyogenes 
dissemination in Lebanon and the region can prove very useful for treatment. The 
sequencing of a larger number of isolates and archiving the respective findings in 
publically available databases could also prove essential for treatment and epidemiology. 
Ultimately, NGS for the analysis of bacterial isolates yields a virtually infinite source of 
genomic information, one that serves as the hallmark of all modern clinical and research 
studies. Complete genomes sequence studies of S. pyogenes are still relatively scarce, and 
hence the importance of this work as being a genome-wide study of the species and 
outlining multiple features of the organism ranging from metabolism to pathogenicity. 
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Chapter Six 
CONCLUSION 
 In this study, which to our knowledge is the first of its kind in Lebanon and the 
region, NGS was used to successfully sequence the genomes of nine S. pyogenes 
isolates isolated from patients with pharyngitis and skin infections. 
 Regulation, signaling, and stress response elements were successfully identified 
with all of the isolates having three to four distinct σ factors, and sets of 
temperature stress response genes. 
 Hyaluronate lyase, CAMP factor, and NADGH encoding genes were found highly 
conserved amongst all the isolates. 
 Two isoforms of the EndoS immunoglobulin degrading enzyme were found, 
EndoS and EndoS F2, spread evenly between the isolates. 
 Streptodronase B encoding genes were detected in all of the isolates and found as 
part of the SpeB-SpeF regulon. 
 A large variety of fibronectin binding proteins was identified in all the isolates at 
three different locations. 
 The C5a peptidase was present and highly conserved amongst all the isolates. 
 All the isolates were found to have an FCT-3 type of the FCT regulon with only 
JI8 having an FCT-1 organization. 
 The M protein family, in addition to the Mga regulon itself showed large 
variations between the isolates. 
 Seven distinct Sag profile were detected, with SpeBGKZ SpeBGJZ being the two 
most prevalent. 
 The overall pathogenic features of the isolates molecularly associated them with 
throat and skin infections, and did not exclude their potential invasiveness. 
 All the isolates showed fluoroquinolone and macrolide resistance genes, with one 
isolate having an additional rare resistance to tetracyclines. 
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 Bacteriophages were detected in all of the samples, conferring superantigen genes 
and genes generally associated with invasive streptococcal diseases and 
resistance. 
 CRISPRs were identified in all of the isolates with an average of two systems per 
isolate. 
 Phylogenetic evolutionary relationships were studied based on SPNs analysis, 
showing diversity in the isolates even within same or closely related clones and 
serotypes. 
 Individual isolates were phylogenetically linked to world-wide clones causing 
more serious invasive diseases. 
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ANNEX I 
 
  
 
Figure 1: Circular representation of the S. pyogenes JI2 genome. The tracks represent 
(Outside inwards) coding sequences on the forward strand, coding sequences on the 
reverse strand, rRNAs, tRNAs, putative phages and phage elements, GC plot and GC 
skew with black indicating above average values and grey indicating below average ones.  
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Figure 12: Circular representation of the S. pyogenes JI3 genome. The tracks represent 
(Outside inwards) coding sequences on the forward strand, coding sequences on the 
reverse strand, rRNAs, tRNAs, putative phages and phage elements, GC plot and GC 
skew with black indicating above average values and grey indicating below average ones. 
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Figure 3: Circular representation of the S. pyogenes JI4 genome. The tracks represent 
(Outside inwards) coding sequences on the forward strand, coding sequences on the 
reverse strand, rRNAs, tRNAs, putative phages and phage elements, GC plot and GC 
skew with black indicating above average values and grey indicating below average ones. 
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Figure 4: Circular representation of the S. pyogenes JI5 genome. The tracks represent 
(Outside inwards) coding sequences on the forward strand, coding sequences on the 
reverse strand, rRNAs, tRNAs, putative phages and phage elements, GC plot and GC 
skew with black indicating above average values and grey indicating below average ones. 
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Figure 5: Circular representation of the S. pyogenes JI7 genome. The tracks represent 
(Outside inwards) coding sequences on the forward strand, coding sequences on the 
reverse strand, rRNAs, tRNAs, putative phages and phage elements, GC plot and GC 
skew with black indicating above average values and grey indicating below average ones. 
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Figure 6: Circular representation of the S. pyogenes JI8 genome. The tracks represent 
(Outside inwards) coding sequences on the forward strand, coding sequences on the 
reverse strand, rRNAs, tRNAs, putative phages and phage elements, GC plot and GC 
skew with black indicating above average values and grey indicating below average ones. 
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Figure 7: Circular representation of the S. pyogenes JI10 genome. The tracks represent 
(Outside inwards) coding sequences on the forward strand, coding sequences on the 
reverse strand, rRNAs, tRNAs, putative phages and phage elements, GC plot and GC 
skew with black indicating above average values and grey indicating below average ones. 
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Figure 8: Comparative circular representation of the S. pyogenes JI2 genome BLASTed 
against the genomes of three reference strains. Circular tracks show (from outside 
inwards) clockwise coding regions, anticlockwise coding regions, S. pyogenes 
MGAS6180 BLAST comparison, S. pyogenes NZ131 BLAST comparison, S. pyogenes 
M1GAS BLAST comparison, GC content, GC skew.  In the BLASTN alignment tracks, 
white regions indicate parts of the input sequence that did not yield a BLAST hit, while 
the color gets gradually darker as the number of hits increases. Regions with a 
pronounced color indicate numerous BLAST hits, such regions are commonly attributed 
to rRNAs or tRNAs or repetitive sequences for which several similar sequences in the 
comparison genome were found. 
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Figure 9: Comparative circular representation of the S. pyogenes JI3 genome BLASTed 
against the genomes of three reference strains. Circular tracks show (from outside 
inwards) clockwise coding regions, anticlockwise coding regions, S. pyogenes 
MGAS6180 BLAST comparison, S. pyogenes NZ131 BLAST comparison, S. pyogenes 
M1GAS BLAST comparison, GC content, GC skew.  In the BLASTN alignment tracks, 
white regions indicate parts of the input sequence that did not yield a BLAST hit, while 
the color gets gradually darker as the number of hits increases. Regions with a 
pronounced color indicate numerous BLAST hits, such regions are commonly attributed 
to rRNAs or tRNAs or repetitive sequences for which several similar sequences in the 
comparison genome were found. 
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Figure 10: Comparative circular representation of the S. pyogenes JI4 genome BLASTed 
against the genomes of three reference strains. Circular tracks show (from outside 
inwards) clockwise coding regions, anticlockwise coding regions, S. pyogenes 
MGAS6180 BLAST comparison, S. pyogenes NZ131 BLAST comparison, S. pyogenes 
M1GAS BLAST comparison, GC content, GC skew.  In the BLASTN alignment tracks, 
white regions indicate parts of the input sequence that did not yield a BLAST hit, while 
the color gets gradually darker as the number of hits increases. Regions with a 
pronounced color indicate numerous BLAST hits, such regions are commonly attributed 
to rRNAs or tRNAs or repetitive sequences for which several similar sequences in the 
comparison genome were found. 
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Figure 11: Comparative circular representation of the S. pyogenes JI6 genome BLASTed 
against the genomes of three reference strains. Circular tracks show (from outside 
inwards) clockwise coding regions, anticlockwise coding regions, S. pyogenes 
MGAS6180 BLAST comparison, S. pyogenes NZ131 BLAST comparison, S. pyogenes 
M1GAS BLAST comparison, GC content, GC skew.  In the BLASTN alignment tracks, 
white regions indicate parts of the input sequence that did not yield a BLAST hit, while 
the color gets gradually darker as the number of hits increases. Regions with a 
pronounced color indicate numerous BLAST hits, such regions are commonly attributed 
to rRNAs or tRNAs or repetitive sequences for which several similar sequences in the 
comparison genome were found. 
110 
 
 
 
Figure 12: Comparative circular representation of the S. pyogenes JI7 genome BLASTed 
against the genomes of three reference strains. Circular tracks show (from outside 
inwards) clockwise coding regions, anticlockwise coding regions, S. pyogenes 
MGAS6180 BLAST comparison, S. pyogenes NZ131 BLAST comparison, S. pyogenes 
M1GAS BLAST comparison, GC content, GC skew.  In the BLASTN alignment tracks, 
white regions indicate parts of the input sequence that did not yield a BLAST hit, while 
the color gets gradually darker as the number of hits increases. Regions with a 
pronounced color indicate numerous BLAST hits, such regions are commonly attributed 
to rRNAs or tRNAs or repetitive sequences for which several similar sequences in the 
comparison genome were found. 
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Figure 13: Comparative circular representation of the S. pyogenes JI8 genome BLASTed 
against the genomes of three reference strains. Circular tracks show (from outside 
inwards) clockwise coding regions, anticlockwise coding regions, S. pyogenes 
MGAS6180 BLAST comparison, S. pyogenes NZ131 BLAST comparison, S. pyogenes 
M1GAS BLAST comparison, GC content, GC skew.  In the BLASTN alignment tracks, 
white regions indicate parts of the input sequence that did not yield a BLAST hit, while 
the color gets gradually darker as the number of hits increases. Regions with a 
pronounced color indicate numerous BLAST hits, such regions are commonly attributed 
to rRNAs or tRNAs or repetitive sequences for which several similar sequences in the 
comparison genome were found. 
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Figure 14: Comparative circular representation of the S. pyogenes JI10 genome 
BLASTed against the genomes of three reference strains. Circular tracks show (from 
outside inwards) clockwise coding regions, anticlockwise coding regions, S. pyogenes 
MGAS6180 BLAST comparison, S. pyogenes NZ131 BLAST comparison, S. pyogenes 
M1GAS BLAST comparison, GC content, GC skew.  In the BLASTN alignment tracks, 
white regions indicate parts of the input sequence that did not yield a BLAST hit, while 
the color gets gradually darker as the number of hits increases. Regions with a 
pronounced color indicate numerous BLAST hits, such regions are commonly attributed 
to rRNAs or tRNAs or repetitive sequences for which several similar sequences in the 
comparison genome were found. 
